0001328792--03-31 2025 Q3 false 8777432 8777432 P3M P36M P36M P18M http://www.tech.pre.com/20241231#FederalHomeLoanBankOfBostonClassicAdvanceRateMember 0001328792 tpcs:RanorIncMember tpcs:RanorTermLoanMember 2024-12-31 0001328792 tpcs:RanorIncMember tpcs:StadcoTermLoanAt3.79PercentInterestDueAugust2028Member 2024-03-31 0001328792 us-gaap:CommonStockMember 2023-10-01 2023-12-31 0001328792 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001328792 2024-07-03 2024-07-03 0001328792 us-gaap:RetainedEarningsMember 2024-12-31 0001328792 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001328792 us-gaap:RetainedEarningsMember 2024-09-30 0001328792 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001328792 us-gaap:RetainedEarningsMember 2024-06-30 0001328792 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001328792 2024-06-30 0001328792 us-gaap:RetainedEarningsMember 2024-03-31 0001328792 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001328792 us-gaap:RetainedEarningsMember 2023-12-31 0001328792 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001328792 us-gaap:RetainedEarningsMember 2023-09-30 0001328792 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001328792 2023-09-30 0001328792 us-gaap:RetainedEarningsMember 2023-06-30 0001328792 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001328792 2023-06-30 0001328792 us-gaap:RetainedEarningsMember 2023-03-31 0001328792 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001328792 us-gaap:CommonStockMember 2024-10-01 2024-12-31 0001328792 us-gaap:CommonStockMember 2024-12-31 0001328792 us-gaap:CommonStockMember 2024-09-30 0001328792 us-gaap:CommonStockMember 2024-06-30 0001328792 us-gaap:CommonStockMember 2024-03-31 0001328792 us-gaap:CommonStockMember 2023-12-31 0001328792 us-gaap:CommonStockMember 2023-09-30 0001328792 us-gaap:CommonStockMember 2023-06-30 0001328792 us-gaap:CommonStockMember 2023-03-31 0001328792 tpcs:RangeTwoMember 2024-04-01 2024-12-31 0001328792 tpcs:RangeOneMember 2024-04-01 2024-12-31 0001328792 srt:MaximumMember 2024-04-01 2024-12-31 0001328792 srt:MaximumMember tpcs:EquityIncentivePlan2016Member 2024-12-31 0001328792 us-gaap:SalesMember 2024-04-01 2024-12-31 0001328792 us-gaap:AccountsReceivableMember 2024-04-01 2024-12-31 0001328792 srt:MinimumMember 2024-12-31 0001328792 srt:MaximumMember 2024-12-31 0001328792 us-gaap:TransferredOverTimeMember 2024-10-01 2024-12-31 0001328792 us-gaap:TransferredAtPointInTimeMember 2024-10-01 2024-12-31 0001328792 tpcs:IndustrialMember 2024-10-01 2024-12-31 0001328792 tpcs:DefenseMember 2024-10-01 2024-12-31 0001328792 us-gaap:TransferredOverTimeMember 2024-04-01 2024-12-31 0001328792 us-gaap:TransferredAtPointInTimeMember 2024-04-01 2024-12-31 0001328792 tpcs:IndustrialMember 2024-04-01 2024-12-31 0001328792 tpcs:DefenseMember 2024-04-01 2024-12-31 0001328792 us-gaap:TransferredOverTimeMember 2023-10-01 2023-12-31 0001328792 us-gaap:TransferredAtPointInTimeMember 2023-10-01 2023-12-31 0001328792 tpcs:DefenseMember 2023-10-01 2023-12-31 0001328792 us-gaap:TransferredOverTimeMember 2023-04-01 2023-12-31 0001328792 us-gaap:TransferredAtPointInTimeMember 2023-04-01 2023-12-31 0001328792 tpcs:IndustrialMember 2023-04-01 2023-12-31 0001328792 tpcs:DefenseMember 2023-04-01 2023-12-31 0001328792 us-gaap:IntersegmentEliminationMember 2024-04-01 2024-12-31 0001328792 us-gaap:IntersegmentEliminationMember 2023-10-01 2023-12-31 0001328792 us-gaap:IntersegmentEliminationMember 2023-04-01 2023-12-31 0001328792 us-gaap:LandMember 2024-12-31 0001328792 us-gaap:ConstructionInProgressMember 2024-12-31 0001328792 us-gaap:BuildingAndBuildingImprovementsMember 2024-12-31 0001328792 tpcs:MachineryEquipmentFurnitureAndFixturesMember 2024-12-31 0001328792 us-gaap:LandMember 2024-03-31 0001328792 us-gaap:ConstructionInProgressMember 2024-03-31 0001328792 us-gaap:BuildingAndBuildingImprovementsMember 2024-03-31 0001328792 tpcs:MachineryEquipmentFurnitureAndFixturesMember 2024-03-31 0001328792 us-gaap:SubsequentEventMember 2025-02-11 2025-02-11 0001328792 us-gaap:OperatingSegmentsMember tpcs:StadcoAcquisitionLlcMember 2024-10-01 2024-12-31 0001328792 us-gaap:OperatingSegmentsMember tpcs:RanorIncMember 2024-10-01 2024-12-31 0001328792 us-gaap:CorporateNonSegmentMember 2024-10-01 2024-12-31 0001328792 us-gaap:OperatingSegmentsMember tpcs:StadcoAcquisitionLlcMember 2024-04-01 2024-12-31 0001328792 us-gaap:OperatingSegmentsMember tpcs:RanorIncMember 2024-04-01 2024-12-31 0001328792 us-gaap:CorporateNonSegmentMember 2024-04-01 2024-12-31 0001328792 us-gaap:OperatingSegmentsMember tpcs:StadcoAcquisitionLlcMember 2023-10-01 2023-12-31 0001328792 us-gaap:OperatingSegmentsMember tpcs:RanorIncMember 2023-10-01 2023-12-31 0001328792 us-gaap:CorporateNonSegmentMember 2023-10-01 2023-12-31 0001328792 us-gaap:OperatingSegmentsMember tpcs:StadcoAcquisitionLlcMember 2023-04-01 2023-12-31 0001328792 us-gaap:OperatingSegmentsMember tpcs:RanorIncMember 2023-04-01 2023-12-31 0001328792 us-gaap:CorporateNonSegmentMember 2023-04-01 2023-12-31 0001328792 us-gaap:RetainedEarningsMember 2024-10-01 2024-12-31 0001328792 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001328792 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001328792 us-gaap:RetainedEarningsMember 2023-10-01 2023-12-31 0001328792 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001328792 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001328792 2023-04-01 2023-06-30 0001328792 tpcs:RevolverLoanMember 2024-05-28 0001328792 tpcs:RevolverLoanMember 2024-05-24 0001328792 tpcs:RevolverLoanMember 2024-05-23 0001328792 tpcs:RevolverLoanMember tpcs:RanorTermLoanMember 2016-12-21 0001328792 tpcs:BerkshireLoanMember 2024-12-31 0001328792 us-gaap:OperatingSegmentsMember 2023-10-01 2023-12-31 0001328792 tpcs:RevolverLoanMember 2024-04-01 2024-12-31 0001328792 tpcs:RevolverLoanMember 2023-04-01 2023-12-31 0001328792 tpcs:RestrictedStockIssuedOnNovember262024Member 2024-12-31 0001328792 tpcs:RestrictedStockIssuedOnAugust32023Member 2024-12-31 0001328792 tpcs:RestrictedStockIssuedOnNovember262024Member 2024-04-01 2024-12-31 0001328792 tpcs:RestrictedStockIssuedOnAugust32023Member 2024-04-01 2024-12-31 0001328792 us-gaap:RevolvingCreditFacilityMember tpcs:RanorTermLoanMember 2024-12-31 0001328792 us-gaap:RevolvingCreditFacilityMember tpcs:RanorTermLoanMember 2024-03-31 0001328792 tpcs:StadcoTermLoanAt3.79InterestDueAugust2028Member 2021-08-25 2021-08-25 0001328792 us-gaap:SecuredDebtMember tpcs:BerkshireLoanMember 2022-12-23 2022-12-23 0001328792 us-gaap:SecuredDebtMember tpcs:BerkshireLoanMember 2017-01-20 0001328792 tpcs:RanorIncMember tpcs:RevolverLoanMember tpcs:StadcoTermLoanAt3.79PercentInterestDueAugust2028Member 2021-08-25 0001328792 tpcs:StadcoTermLoanAt3.79PercentInterestDueAugust2028Member 2021-08-25 0001328792 tpcs:RanorIncMember us-gaap:SecuredDebtMember tpcs:BerkshireLoanMember 2016-12-21 0001328792 tpcs:StadcoTermLoanAt3.79PercentInterestDueAugust2028Member 2024-12-31 0001328792 tpcs:StadcoEquipmentFinancingAt13.38InterestDueSeptember2026Member 2024-12-31 0001328792 tpcs:RanorTermLoanAt6.05InterestDueDecember2027Member 2024-12-31 0001328792 tpcs:RanorRevolverLoanDueApril2025Member 2024-12-31 0001328792 tpcs:StadcoTermLoanAt3.79PercentInterestDueAugust2028Member 2024-03-31 0001328792 tpcs:RanorTermLoanAt6.05InterestDueDecember2027Member 2024-03-31 0001328792 tpcs:RanorRevolverLoanDueApril2025Member 2024-03-31 0001328792 2024-06-01 2024-06-01 0001328792 2024-05-31 2024-05-31 0001328792 tpcs:StadcoTermLoanAt3.79PercentInterestDueAugust2028Member 2021-08-25 2021-08-25 0001328792 tpcs:DeferredRevenueMember 2024-12-31 0001328792 tpcs:CustomerDepositsMember 2024-12-31 0001328792 tpcs:DeferredRevenueMember 2024-03-31 0001328792 tpcs:CustomerDepositsMember 2024-03-31 0001328792 us-gaap:UnbilledRevenuesMember 2024-12-31 0001328792 tpcs:AdjustmentsProgressPaymentsReceivableMember 2024-12-31 0001328792 us-gaap:UnbilledRevenuesMember 2024-03-31 0001328792 tpcs:AdjustmentsProgressPaymentsReceivableMember 2024-03-31 0001328792 tpcs:EquipmentFinancingAgreementMember 2024-12-31 0001328792 tpcs:CustomerFMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-10-01 2024-12-31 0001328792 tpcs:CustomerEMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-10-01 2024-12-31 0001328792 tpcs:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-10-01 2024-12-31 0001328792 tpcs:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-10-01 2024-12-31 0001328792 tpcs:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-10-01 2024-12-31 0001328792 tpcs:Customers.Member tpcs:TradeReceivablesMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2024-12-31 0001328792 tpcs:CustomerIMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2024-12-31 0001328792 tpcs:CustomerFMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2024-12-31 0001328792 tpcs:CustomerEMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2024-12-31 0001328792 tpcs:CustomerEMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2024-12-31 0001328792 tpcs:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2024-12-31 0001328792 tpcs:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2024-12-31 0001328792 tpcs:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2024-12-31 0001328792 tpcs:CustomerEMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-10-01 2023-12-31 0001328792 tpcs:CustomerDMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-10-01 2023-12-31 0001328792 tpcs:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-10-01 2023-12-31 0001328792 tpcs:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-10-01 2023-12-31 0001328792 tpcs:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-10-01 2023-12-31 0001328792 tpcs:CustomerHMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2024-03-31 0001328792 tpcs:CustomerEMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2024-03-31 0001328792 tpcs:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2024-03-31 0001328792 tpcs:CustomerEMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2023-12-31 0001328792 tpcs:CustomerDMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2023-12-31 0001328792 tpcs:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2023-12-31 0001328792 tpcs:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2023-12-31 0001328792 tpcs:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2023-12-31 0001328792 2024-07-03 0001328792 tpcs:EquityIncentivePlan2016Member 2024-12-31 0001328792 2023-03-31 0001328792 tpcs:BerkshireLoanMember 2024-04-01 2024-12-31 0001328792 us-gaap:OperatingSegmentsMember tpcs:StadcoAcquisitionLlcMember 2024-12-31 0001328792 us-gaap:OperatingSegmentsMember tpcs:RanorIncMember 2024-12-31 0001328792 us-gaap:CorporateNonSegmentMember 2024-12-31 0001328792 us-gaap:OperatingSegmentsMember tpcs:StadcoAcquisitionLlcMember 2023-12-31 0001328792 us-gaap:OperatingSegmentsMember tpcs:RanorIncMember 2023-12-31 0001328792 us-gaap:CorporateNonSegmentMember 2023-12-31 0001328792 2023-12-31 0001328792 us-gaap:WarrantMember 2024-10-01 2024-12-31 0001328792 us-gaap:RestrictedStockMember 2024-10-01 2024-12-31 0001328792 us-gaap:EmployeeStockOptionMember 2024-10-01 2024-12-31 0001328792 us-gaap:WarrantMember 2024-04-01 2024-12-31 0001328792 us-gaap:RestrictedStockMember 2024-04-01 2024-12-31 0001328792 us-gaap:EmployeeStockOptionMember 2024-04-01 2024-12-31 0001328792 us-gaap:WarrantMember 2023-10-01 2023-12-31 0001328792 us-gaap:EmployeeStockOptionMember 2023-10-01 2023-12-31 0001328792 us-gaap:WarrantMember 2023-04-01 2023-12-31 0001328792 us-gaap:EmployeeStockOptionMember 2023-04-01 2023-12-31 0001328792 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001328792 2024-07-01 2024-09-30 0001328792 us-gaap:AdditionalPaidInCapitalMember 2023-10-01 2023-12-31 0001328792 2023-10-01 2023-12-31 0001328792 us-gaap:AdditionalPaidInCapitalMember 2024-10-01 2024-12-31 0001328792 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001328792 2023-07-01 2023-09-30 0001328792 tpcs:CustomerIMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-12-31 0001328792 tpcs:CustomerEMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-12-31 0001328792 tpcs:CustomerHMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-03-31 0001328792 tpcs:CustomerEMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-03-31 0001328792 tpcs:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-03-31 0001328792 tpcs:RevolverLoanMember tpcs:BerkshireLoanMember 2024-09-30 0001328792 2024-09-30 0001328792 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001328792 2024-04-01 2024-06-30 0001328792 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001328792 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001328792 us-gaap:PrivatePlacementMember 2024-07-03 2024-07-03 0001328792 us-gaap:PrivatePlacementMember 2024-04-01 2024-12-31 0001328792 tpcs:RangeTwoMember 2024-12-31 0001328792 tpcs:RangeOneMember 2024-12-31 0001328792 2023-04-01 2024-03-31 0001328792 tpcs:RestrictedCommonStockAwardedOnJanuary242024Member tpcs:EquityIncentivePlan2016Member 2024-01-24 2024-01-24 0001328792 tpcs:RestrictedStockIssuedOnNovember262024Member 2024-11-26 2024-11-26 0001328792 tpcs:RestrictedStockIssuedOnAugust32023Member 2023-08-03 2023-08-03 0001328792 us-gaap:PrivatePlacementMember 2024-07-03 0001328792 tpcs:RevolverLoanMember tpcs:BerkshireLoanMember 2024-03-20 2024-03-20 0001328792 tpcs:RevolverLoanMember tpcs:BerkshireLoanMember 2023-12-20 2023-12-20 0001328792 tpcs:RanorIncMember tpcs:RanorTermLoanMember 2021-08-25 2021-08-25 0001328792 tpcs:PaymentArrangementAgreementWithDepartmentOfWaterAndPowerOfCityOfLosAngelesMember 2024-12-31 0001328792 us-gaap:PropertyPlantAndEquipmentMember 2021-08-25 0001328792 us-gaap:OperatingSegmentsMember 2024-10-01 2024-12-31 0001328792 us-gaap:OperatingSegmentsMember 2024-04-01 2024-12-31 0001328792 us-gaap:OperatingSegmentsMember 2023-04-01 2023-12-31 0001328792 tpcs:TradeReceivablesMember 2024-04-01 2024-12-31 0001328792 tpcs:RevolverLoanMember tpcs:BerkshireLoanMember 2014-04-01 2014-12-31 0001328792 us-gaap:RevolvingCreditFacilityMember tpcs:RanorTermLoanMember 2016-12-21 0001328792 2014-12-31 0001328792 us-gaap:SubsequentEventMember 2025-02-11 0001328792 us-gaap:RevolvingCreditFacilityMember tpcs:RanorTermLoanMember 2024-04-01 2024-12-31 0001328792 us-gaap:RevolvingCreditFacilityMember tpcs:RanorTermLoanMember 2023-04-01 2024-03-31 0001328792 us-gaap:PropertyPlantAndEquipmentMember 2021-08-25 2021-08-25 0001328792 tpcs:EquipmentFinancingAgreementMember 2024-05-01 2024-05-01 0001328792 us-gaap:NotesPayableOtherPayablesMember tpcs:BerkshireLoanMember 2016-12-21 2016-12-21 0001328792 us-gaap:RevolvingCreditFacilityMember tpcs:BerkshireLoanMember 2016-12-21 2016-12-21 0001328792 tpcs:RanorIncMember tpcs:BerkshireLoanMember 2024-04-01 2024-12-31 0001328792 srt:MinimumMember tpcs:BerkshireLoanMember 2024-12-31 0001328792 srt:MaximumMember tpcs:BerkshireLoanMember 2024-12-31 0001328792 srt:ChiefFinancialOfficerMember 2023-07-13 2023-07-13 0001328792 srt:MinimumMember tpcs:BerkshireLoanMember 2024-04-01 2024-12-31 0001328792 srt:MaximumMember tpcs:BerkshireLoanMember 2024-04-01 2024-12-31 0001328792 tpcs:StadcoAcquisitionLlcMember 2024-04-01 2024-12-31 0001328792 tpcs:RanorIncMember 2024-04-01 2024-12-31 0001328792 tpcs:StadcoAcquisitionLlcMember 2023-04-01 2023-12-31 0001328792 tpcs:RanorIncMember 2023-04-01 2023-12-31 0001328792 2023-04-01 2023-12-31 0001328792 us-gaap:RevolvingCreditFacilityMember tpcs:BerkshireLoanMember 2016-12-21 0001328792 tpcs:PaymentArrangementAgreementWithDepartmentOfWaterAndPowerOfCityOfLosAngelesMember 2023-03-31 0001328792 2024-12-31 0001328792 2024-03-31 0001328792 2024-04-29 2024-04-29 0001328792 2024-04-01 2024-04-30 0001328792 2024-10-01 2024-12-31 0001328792 2025-03-31 0001328792 2024-04-01 2024-12-31 xbrli:shares iso4217:USD xbrli:pure tpcs:item tpcs:customer iso4217:USD xbrli:shares tpcs:director

Table of Contents

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2024

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-41698

TechPrecision Corporation

(Exact name of registrant as specified in its charter)

​

Delaware |  | 51-0539828
(State or other jurisdiction of |  | (I.R.S. Employer
incorporation or organization) |  | Identification No.)

​

1 Bella Drive |  |
Westminster, MA |  | 01473
(Address of principal executive offices) |  | (Zip Code)
Registrant’s telephone number, including area code |  | (978) 874-0591

​

Securities registered pursuant to Section 12(b) of the Act:

​

Title of each class |  | Trading Symbol(s) |  | Name of each exchange on which registered
Common Stock, par value $0.0001 per share |  | TPCS |  | Nasdaq Capital Market

​

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

​

Large accelerated filer | ☐ |  |  | Accelerated filer | ☐
Non-accelerated filer | ☒ |  |  | Smaller reporting company | ☒
Emerging growth company | ☐ | ​

​

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. ☐

​

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

☐ Yes ☒ No

​

The number of shares outstanding of the registrant’s common stock as of March 31, 2025, was 9,751,825.

​

​

​

Table of Contents

TABLE OF CONTENTS

​ | ​ |
​ | ​ | Page
PART I. | FINANCIAL INFORMATION | 3
ITEM 1. | FINANCIAL STATEMENTS (UNAUDITED) | 3
​ | CONDENSED CONSOLIDATED BALANCE SHEETS | 3
​ | CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | 4
​ | CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY | 5
​ | CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | 6
​ | NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS | 8
ITEM 2. | MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS | 22
ITEM 3. | QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK | 36
ITEM 4. | CONTROLS AND PROCEDURES | 36
ITEM 5. | OTHER INFORMATION | 38
PART II. | OTHER INFORMATION | 39
ITEM 1. | LEGAL PROCEEDINGS | 39
ITEM 6. | EXHIBITS | 40
​ | SIGNATURES | 41

​

​

​

2

Table of Contents

PART I

ITEM 1. FINANCIAL STATEMENTS

TECHPRECISION CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | (Unaudited) | ​ | ​
​ | ​ | December 31, | ​ | March 31,
(in thousands, except per share data) |  | 2024 |  | 2024
ASSETS | ​ | ​ | ​ | ​ | ​ | ​
Current assets: | ​ | ​ | ​ | ​ | ​ | ​
Cash and cash equivalents | ​ | $ | 165 | ​ | $ | 138
Accounts receivable, net | ​ |  | 1,970 | ​ |  | 2,371
Contract assets | ​ |  | 8,417 | ​ |  | 8,527
Raw materials | ​ | ​ | 1,871 | ​ | ​ | 1,827
Work-in-process | ​ | ​ | 1,329 | ​ | ​ | 1,423
Other current assets | ​ |  | 375 | ​ | ​ | 564
Total current assets | ​ |  | 14,127 | ​ | ​ | 14,850
Property, plant and equipment, net | ​ |  | 13,463 | ​ | ​ | 14,798
Right of use asset, net | ​ | ​ | 4,449 | ​ | ​ | 4,977
Other noncurrent assets | ​ |  | 121 | ​ | ​ | 122
Total assets | ​ | $ | 32,160 | ​ | $ | 34,747
LIABILITIES AND STOCKHOLDERS’ EQUITY: | ​ | ​ | ​ | ​ | ​ | ​
Current liabilities: | ​ | ​ | ​ | ​ | ​ | ​
Accounts payable | ​ | $ | 1,833 | ​ | $ | 1,408
Accrued expenses | ​ |  | 3,344 | ​ | ​ | 4,263
Contract liabilities | ​ |  | 2,667 | ​ | ​ | 3,788
Current portion of long-term lease liability | ​ |  | 761 | ​ | ​ | 736
Current portion of long-term debt, net | ​ | ​ | 7,278 | ​ | ​ | 7,559
Total current liabilities | ​ |  | 15,883 | ​ | ​ | 17,754
Long-term equipment financing | ​ |  | 19 | ​ | ​ | —
Long-term lease liability | ​ | ​ | 3,834 | ​ | ​ | 4,408
Other noncurrent liability | ​ | ​ | 4,323 | ​ | ​ | 4,782
Total liabilities | ​ | ​ | 24,059 | ​ | ​ | 26,944
Commitments (see Note 14) | ​ | ​ | ​ | ​ | ​ | ​
Stockholders’ Equity: | ​ | ​ | ​ | ​ | ​ | ​
Common stock - par value $0.0001 per share, 50,000,000 shares authorized; Shares issued and outstanding December 31, 2024 – 9,662,525 and 9,607,525, respectively; Shares issued and outstanding March 31, 2024 – 8,777,432. | ​ |  | 1 | ​ | ​ | 1
Additional paid in capital | ​ |  | 18,359 | ​ | ​ | 15,201
Accumulated deficit | ​ |  | (10,259) | ​ | ​ | (7,399)
Total stockholders’ equity | ​ |  | 8,101 | ​ | ​ | 7,803
Total liabilities and stockholders’ equity | ​ | $ | 32,160 | ​ | $ | 34,747

​

See accompanying notes to the condensed consolidated financial statements.

​

3

Table of Contents

TECHPRECISION CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended December 31, | ​ | Nine Months Ended December 31,
(in thousands, except per share data) |  | 2024 |  | 2023 |  | 2024 |  | 2023
Revenue | ​ | $ | 7,622 | ​ | $ | 7,650 | ​ | $ | 24,554 | ​ | $ | 22,991
Cost of revenue | ​ |  | 6,631 | ​ | ​ | 6,489 | ​ | ​ | 22,310 | ​ | ​ | 20,101
Gross profit | ​ |  | 991 | ​ | ​ | 1,161 | ​ | ​ | 2,244 | ​ | ​ | 2,890
Selling, general and administrative | ​ |  | 1,687 | ​ | ​ | 2,157 | ​ | ​ | 4,769 | ​ | ​ | 5,063
Loss from operations | ​ | ​ | (696) | ​ | ​ | (996) | ​ | ​ | (2,525) | ​ | ​ | (2,173)
Other income | ​ |  | 44 | ​ | ​ | — | ​ | ​ | 57 | ​ | ​ | 41
Interest expense | ​ |  | (147) | ​ | ​ | (110) | ​ | ​ | (392) | ​ | ​ | (353)
Total other income (expense), net | ​ |  | (103) | ​ | ​ | (110) | ​ | ​ | (335) | ​ | ​ | (312)
Loss before income taxes | ​ |  | (799) | ​ | ​ | (1,106) | ​ | ​ | (2,860) | ​ | ​ | (2,485)
Income tax benefit | ​ | ​ | — | ​ | ​ | (241) | ​ | ​ | — | ​ | ​ | (564)
Net loss | ​ | $ | (799) | ​ | $ | (865) | ​ | $ | (2,860) | ​ | $ | (1,921)
Net loss per share - basic and diluted | ​ | $ | (0.08) | ​ | $ | (0.10) | ​ | $ | (0.30) | ​ | $ | (0.22)
Weighted average shares outstanding – basic and diluted | ​ | ​ | 9,607,785 | ​ | ​ | 8,759,171 | ​ | ​ | 9,389,346 | ​ | ​ | 8,698,034

​

See accompanying notes to the condensed consolidated financial statements.

​

4

Table of Contents

TECHPRECISION CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (unaudited)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | ​ |  | Additional |  | ​ |  | Total
​ |  | Common | ​ | Par |  | Paid in |  | Accumulated |  | Stockholders’
(in thousands, except per share data) |  | Stock |  | Value |  | Capital |  | Deficit |  | Equity
Balance March 31, 2023 | ​ | 8,613,408 | ​ | $ | 1 | ​ | $ | 14,950 | ​ | $ | (356) | ​ | $ | 14,595
Net loss | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (528) | ​ | ​ | (528)
Balance June 30, 2023 | ​ | 8,613,408 | ​ | $ | 1 | ​ | $ | 14,950 | ​ | $ | (884) | ​ | $ | 14,067
Stock issued for exercised options | ​ | 109,024 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | —
Stock used for tax withholding at exercise | ​ | — | ​ | ​ | — | ​ | ​ | (34) | ​ | ​ | — | ​ | ​ | (34)
Restricted stock award | ​ | 15,000 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | —
Stock-based compensation | ​ | — | ​ | ​ | — | ​ | ​ | 9 | ​ | ​ | — | ​ | ​ | 9
Net loss | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (528) | ​ | ​ | (528)
Balance September 30, 2023 | ​ | 8,737,432 | ​ | $ | 1 | ​ | $ | 14,925 | ​ | $ | (1,412) | ​ | $ | 13,514
Restricted stock award | ​ | 25,000 | ​ | ​ | — | ​ | ​ | 178 | ​ | ​ | — | ​ | ​ | 178
Stock-based compensation | ​ | — | ​ | ​ | — | ​ | ​ | 9 | ​ | ​ | — | ​ | ​ | 9
Net loss | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (865) | ​ | ​ | (865)
Balance December 31, 2023 | ​ | 25,000 | ​ | ​ | 1 | ​ | ​ | 15,112 | ​ | ​ | (2,277) | ​ | ​ | 12,836
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Balance March 31, 2024 | ​ | 8,777,432 | ​ | $ | 1 | ​ | $ | 15,201 | ​ | $ | (7,399) | ​ | $ | 7,803
Stock issued for termination fee | ​ | 320,000 | ​ | ​ | — | ​ | ​ | 1,536 | ​ | ​ | — | ​ | ​ | 1,536
Stock-based compensation | ​ | — | ​ | ​ | — | ​ | ​ | 9 | ​ | ​ | — | ​ | ​ | 9
Net loss | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (1,460) | ​ | ​ | (1,460)
Balance June 30, 2024 | ​ | 9,097,432 | ​ | ​ | 1 | ​ | ​ | 16,746 | ​ | ​ | (8,859) | ​ | ​ | 7,888
Sale of stock and warrants, net | ​ | 521,800 | ​ | ​ | — | ​ | ​ | 1,588 | ​ | ​ | — | ​ | ​ | 1,588
Stock-based compensation | ​ | — | ​ | ​ | — | ​ | ​ | 9 | ​ | ​ | — | ​ | ​ | 9
Net loss | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (601) | ​ | ​ | (601)
Balance September 30, 2024 | ​ | 9,619,232 | ​ | $ | 1 | ​ | $ | 18,343 | ​ | $ | (9,460) | ​ | $ | 8,884
Restricted stock award | ​ | 45,000 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | —
Stock-based compensation | ​ | — | ​ | ​ | — | ​ | ​ | 22 | ​ | ​ | — | ​ | ​ | 22
Stock used for tax withholding | ​ | (1,707) | ​ | ​ | — | ​ | ​ | (6) | ​ | ​ | — | ​ | ​ | (6)
Net loss | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (799) | ​ | ​ | (799)
Balance December 31, 2024 | ​ | 9,662,525 | ​ | $ | 1 | ​ | $ | 18,359 | ​ | ​ | (10,259) | ​ | ​ | 8,101

​

See accompanying notes to the condensed consolidated financial statements.

​

5

Table of Contents

TECHPRECISION CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Nine Months Ended December 31,
(in thousands, except per share data) |  | 2024 |  | 2023
CASH FLOWS FROM OPERATING ACTIVITIES: |  | ​ |  |  | ​ |
Net loss | ​ | $ | (2,860) | ​ | $ | (1,921)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | ​ |  | ​ | ​ |  | ​
Depreciation and amortization | ​ |  | 2,093 | ​ |  | 1,759
Amortization of debt issue costs | ​ |  | 67 | ​ |  | 55
Change in fair value of stock acquisition termination fee | ​ |  | 419 | ​ |  | —
Stock-based compensation | ​ |  | 40 | ​ |  | 196
Change in contract loss provision | ​ |  | 186 | ​ |  | 155
Deferred income taxes | ​ |  | — | ​ |  | (563)
Gain on disposal of fixed assets | ​ | ​ | 1 | ​ | ​ | (40)
Changes in operating assets and liabilities: | ​ |  | ​ | ​ | ​ | ​
Accounts receivable | ​ |  | 401 | ​ |  | 144
Contract assets | ​ |  | 110 | ​ |  | 576
Work-in-process and raw materials | ​ |  | 50 | ​ |  | (1,228)
Other current assets | ​ |  | 189 | ​ |  | (305)
Accounts payable | ​ |  | 425 | ​ |  | (497)
Accrued expenses | ​ |  | (536) | ​ |  | (527)
Contract liabilities | ​ |  | (1,121) | ​ |  | 1,702
Other noncurrent liabilities | ​ | ​ | (459) | ​ | ​ | 1,674
Net cash (used in) provided by operating activities | ​ |  | (995) | ​ |  | 1,180
CASH FLOWS FROM INVESTING ACTIVITIES: | ​ |  | ​ | ​ |  | ​
Proceeds from insurance claim on fixed assets | ​ | ​ | — | ​ | ​ | 62
Purchases of property, plant, and equipment | ​ |  | (2,796) | ​ |  | (2,782)
Reimbursements for purchases of property, plant and equipment | ​ | ​ | 2,566 | ​ | ​ | —
Net cash used in investing activities | ​ | ​ | (230) | ​ | ​ | (2,720)
CASH FLOWS FROM FINANCING ACTIVITIES: | ​ |  | ​ | ​ |  | ​
Proceeds from private placement | ​ | ​ | 1,801 | ​ | ​ | —
Private placement fees | ​ | ​ | (213) | ​ | ​ | —
Debt issue costs | ​ | ​ | (58) | ​ | ​ | (40)
Proceeds from equipment financing | ​ | ​ | 65 | ​ | ​ | —
Revolver loan borrowings | ​ | ​ | 10,526 | ​ | ​ | 10,160
Revolver loan payments | ​ | ​ | (10,381) | ​ | ​ | (8,260)
Payments of principal for leases | ​ | ​ | (7) | ​ | ​ | (15)
Repayments of long-term debt | ​ |  | (481) | ​ | ​ | (448)
Net cash provided by financing activities | ​ |  | 1,252 | ​ |  | 1,397
Net increase (decrease) in cash and cash equivalents | ​ |  | 27 | ​ |  | (143)
Cash and cash equivalents, beginning of period | ​ |  | 138 | ​ |  | 534
Cash and cash equivalents, end of period | ​ | $ | 165 | ​ | $ | 391
SUPPLEMENTAL DISCLOSURES OF CASH FLOWS INFORMATION: | ​ |  | ​ | ​ |  | ​
Cash paid for interest; net of amounts capitalized | ​ | $ | 324 | ​ | $ | 297

​

See accompanying notes to the condensed consolidated financial statements.

6

Table of Contents

SUPPLEMENTAL INFORMATION – NONCASH TRANSACTIONS:

Nine Months ended December 31, 2024

Noncash Operating - On April 29, 2024, we extinguished a liability of $1,117 when we issued 320,000 shares of common stock in connection with a breakup fee payment set forth under an agreement to terminate the acquisition of Votaw Precision Technologies, Inc.

Noncash Financing - On April 29, 2024, we issued 320,000 shares of common stock with a fair value of $1,536 for the breakup fee payment as set forth under an agreement to terminate the acquisition of Votaw Precision Technologies, Inc. The additional $419 was based on the change in fair value of shares at the time of issuance was recorded in April 2024.

Nine Months ended December 31, 2023

Noncash Financing - On July 13, 2023, our former CFO exercised an option to purchase 125,000 shares of the Company’s common stock pursuant to option awards previously granted under the 2016 Plan. The option was exercised as a cashless net settlement transaction and resulted in the delivery of 109,024 shares of common stock on July 13, 2023.

​

7

Table of Contents

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

(in thousands, except per share data)

NOTE 1 - DESCRIPTION OF BUSINESS

TechPrecision Corporation, or “TechPrecision”, is a Delaware corporation organized in February 2005 under the name Lounsberry Holdings II, Inc. On February 24, 2006, we acquired all the issued and outstanding capital stock of our wholly owned subsidiary Ranor, Inc., or “Ranor.” Ranor, together with its predecessors, has been in continuous operation since 1956. The name was changed to TechPrecision Corporation on March 6, 2006.

TechPrecision is the parent company of Ranor, Westminster Credit Holdings, LLC, or “WCH”, Stadco New Acquisition, LLC, or “Acquisition Sub”, and Stadco. TechPrecision, Ranor, WCH, Acquisition Sub and Stadco are collectively referred to as the “Company”, “we”, “us” or “our”.

We are a custom manufacturer of precision, large-scale fabrication components and precision, large-scale machined metal structural components. The components that we manufacture are customer designed. We sell to customers in two main industry sections: defense and precision industrial markets.

NOTE 2 - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation and Consolidation - The accompanying condensed consolidated financial statements include the accounts of TechPrecision, Ranor, Stadco, WCH, and Acquisition Sub. Intercompany transactions and balances have been eliminated in consolidation. The accompanying condensed consolidated balance sheet as of December 31, 2024, the condensed consolidated statements of operations and stockholders’ equity for the three and nine months ended December 31, 2024 and 2023, and the condensed consolidated statements of cash flows for the nine months ended December 31, 2024 and 2023 are unaudited, and, in the opinion of management, include all adjustments that are necessary for a fair presentation of our financial statements for interim periods in accordance with U.S. Generally Accepted Accounting Principles, or “U.S. GAAP”. All adjustments are of a normal, recurring nature, except as otherwise disclosed. The results of operations for an interim period are not necessarily indicative of the results of operations to be expected for the fiscal year.

These notes to the condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission, or the “SEC”, for Quarterly Reports on Form 10-Q. Certain information and disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. These unaudited financial statements and related notes should be read in conjunction with the consolidated financial statements included with our Annual Report on Form 10-K for the fiscal year ended March 31, 2024, filed with the SEC on September 13, 2024.

Use of Estimates in the Preparation of Financial Statements - In preparing the condensed consolidated financial statements in conformity with U.S. GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and revenue and expenses during the reporting period. We continually evaluate our estimates, including those related to revenue recognition and income taxes. We base our estimates on historical and current experiences and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ from those estimates.

Liquidity and Going Concern - Our liquidity is highly dependent on the availability of financing facilities and our ability to generate positive operating cash flow. For the nine months ended December 31, 2024, we reported a net loss of $2,860.

As of December 31, 2024, we had approximately $330 in total available liquidity, consisting primarily of $165 in cash and cash equivalents, and $165 in undrawn capacity under our revolver loan. As of March 31, 2024, we had approximately $677 in total available liquidity, consisting of $138 in cash and cash equivalents, and $539 in undrawn capacity under our revolver loan.

8

Table of Contents

The Company is the borrower under a Loan Agreement which was amended on May 28, 2024, Ranor and certain affiliates of the Company entered into the Eighth Amendment to Amended and Restated Loan Agreement and Fourth Amendment to Second Amended and Restated Promissory Note, or the “Eighth Amendment”. In addition to extending the maturity date of the revolver loan to August 30, 2024, the Eighth Amendment reduced the maximum principal amount from $5,000 to $4,500 and required that an operational assessment be performed, primarily at Stadco, by an acceptable third-party consultant. The lender has acknowledged receipt of that operational assessment of Stadco as required pursuant to the Eighth Amendment.

On September 4, 2024, Ranor and the other Borrowers entered into a Ninth Amendment to Amended and Restated Loan Agreement and Fifth Amendment to Second Amended and Restated Promissory Note, or the “Ninth Amendment”, with Berkshire Bank. Effective August 30, 2024, the Ninth Amendment, among other things, extended the maturity date of the Revolver Loan from August 30, 2024 to January 15, 2025.

On December 19, 2024, Ranor and the other Borrowers entered into a Tenth Amendment to Amended and Restated Loan Agreement and Sixth Amendment to Second Amended and Restated Promissory Note, or the “Tenth Amendment”, with Berkshire Bank. The Tenth Amendment, among other things, extended the maturity date of the Revolver Loan from January 15, 2025 to April 30, 2025.

The Company acknowledges that a certain event of default has occurred and is continuing under the Loan Agreement as a result of the Company’s failure to satisfy the Debt Service Coverage Ratio, or DSCR, for the twelve-month period ending December 31, 2024. The lender reserves any and all rights and remedies available to it under the Loan Agreement, including, without limitation, its right to choose to accelerate and demand the outstanding indebtedness evidenced by the loan documents, and to seek immediate repayment in full.

There was $7,327 in total outstanding debt under the Loan Agreement on December 31, 2024. Without a waiver, the lender has the right, but not the obligation, to demand repayment from the Company for noncompliance with the debt covenants. In addition, the lender retains the right to act on covenant violations that occur after the date of delivery of any waiver. The lender has not granted us a waiver. As such, we need to seek alternative financing to pay these obligations as the Company does not have existing facilities or sufficient cash on hand to satisfy these obligations. It is also probable that the Company will not be in compliance with the same debt covenants at subsequent measurement dates within the next twelve months. As a result of the above, all of our long-term debt has been classified as current in our condensed consolidated balance sheet.

The Company is exploring various means of strengthening its liquidity position and ensuring compliance with its debt financing covenants by improving profitability of Stadco operations, renewing our revolver loan, or entering into alternative debt facilities.

On July 3, 2024, the Company entered into a Securities Purchase Agreement with certain accredited investors, pursuant to which the Company sold 521,800 shares of the Company’s common stock, par value $0.0001 per share, and 521,800 common stock purchase warrants to purchase 521,800 shares of Common Stock in a private placement at an aggregate purchase price of $1,801. The combined purchase price for one share and one warrant was $3.45. The purpose of the private placement was to raise working capital for use by the Company. The closing of the offering occurred on July 8, 2024. Placement fees in connection with the offering totaled $213. In addition, the Company issued to the placement agent common stock purchase warrants to purchase up to 19,983 shares of common stock. On February 11, 2025, the Company received $498 in proceeds from the sale of the remaining shares of the Company’s common stock, and common stock purchase warrants to purchase shares of common stock (see Note 16, Subsequent Events).

In order for us to continue operations beyond the next twelve months from the date of issuance of the financial statements and to be able to discharge our liabilities and commitments in the normal course of business, we must renew our revolver loan by April 30, 2025, or seek alternative financing if the lender calls the loan due to default. We must mitigate our recurring operating losses at our Stadco subsidiary, efficiently increase utilization of our manufacturing capacity, and improve the manufacturing process. We plan to closely monitor our expenses and, if required, will reduce operating costs to enhance liquidity.

The uncertainty associated with the recurring operating losses at Stadco, the revolver loan renewal, the need for alternative financing, and compliance with debt covenants at current and subsequent measurement dates raise substantial doubt about our ability to continue as a going concern for at least one-year after the date the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q are issued.

9

Table of Contents

The condensed consolidated financial statements for the three and nine months ended December 31, 2024, were prepared on the basis of a going concern which contemplates that we will be able to realize assets and discharge liabilities in the normal course of business. Accordingly, they do not give effect to adjustments that would be necessary should we be required to liquidate assets. Our ability to satisfy our current liabilities and to continue as a going concern is dependent upon the Company’s compliance with the debt covenants, renewing the revolver loan, and its ability to grow revenue and reduce costs at Stadco. The condensed consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

New Accounting Standards Not Yet Adopted

In November 2024, the Financial Accounting Standards Board, or the “FASB”, issued Accounting Standards Update, or “ASU”, 2024 - 03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220 - 40), Disaggregation of Income Statement Expenses. The ASU will require the Company to provide more detailed information about the types of expenses (including purchases of inventory, employee compensation, depreciation, amortization, and depletion) in commonly presented expense captions (such as cost of sales, SG&A, and research and development). The ASU does not change the expense captions an entity presents on the face of the income statement. The amendments in this update are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. The Company is currently evaluating this update to determine the impact it may have on the disclosures to its condensed consolidated financial statements.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amendments in ASU 2023-09 address investor requests for more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. This standard update is effective for annual reporting periods beginning after December 15, 2024. The Company is currently evaluating this update to determine the impact it may have on the disclosures to the consolidated financial statements.

In November 2023, the FASB issued ASU 2023-07, Segment Reporting – Improvements to Reportable Segment Disclosures. The guidance in this update enhances segment reporting by expanding the breadth and frequency of segment disclosures required for public entities and allows registrants to disclose multiple measures of segment profit or loss. This update requires a public entity to disclose its significant segment expense categories and amounts for each reportable segment. A significant segment expense is any significant expense incurred by the segment, including direct expenses, shared expenses, allocated corporate overhead, or interest expense that is regularly reported to the Chief Operating Decision Maker, or CODM, and is included in the measure of segment profit or loss. This standard update is effective for fiscal years beginning after December 15, 2023, and interim periods in fiscal years beginning after December 15, 2024. The Company is currently evaluating this update to determine the impact it may have on the disclosures to its condensed consolidated financial statements and will apply the guidance retrospectively.

​

NOTE 3 – REVENUE

The Company generates revenue primarily from performance obligations completed under contracts with customers in two main market sectors: defense and precision industrial. The period over which the Company performs its obligations is generally between three and thirty-six months. Revenue is recognized over-time or at a point-in-time given the terms and conditions of the related contracts. The Company utilizes an inputs methodology based on estimated labor hours to measure performance progress. This model best depicts the transfer of control to the customer. The Company’s contract portfolio is comprised of fixed-price contracts and provide for product type revenue only. The following table presents revenue on a disaggregated basis by market and contract type:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Revenue by market |  | Defense |  | Industrial |  | Totals
Three months ended December 31, 2024 | ​ | $ | 7,456 | ​ | $ | 166 | ​ | $ | 7,622
Three months ended December 31, 2023 | ​ | $ | 7,650 | ​ | $ | — | ​ | $ | 7,650
Nine months ended December 31, 2024 | ​ | $ | 24,317 | ​ | $ | 237 | ​ | $ | 24,554
Nine months ended December 31, 2023 | ​ | $ | 22,809 | ​ | $ | 182 | ​ | $ | 22,991

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Revenue by contract type |  | Over-Time |  | Point-in-Time |  | Totals
Three months ended December 31, 2024 | ​ | $ | 7,297 | ​ | $ | 325 | ​ | $ | 7,622
Three months ended December 31, 2023 | ​ | $ | 7,416 | ​ | $ | 234 | ​ | $ | 7,650
Nine months ended December 31, 2024 | ​ | $ | 23,158 | ​ | $ | 1,396 | ​ | $ | 24,554
Nine months ended December 31, 2023 | ​ | $ | 21,763 | ​ | $ | 1,228 | ​ | $ | 22,991

​

As of December 31, 2024, the Company had $45,522 of remaining performance obligations, of which $37,701 were less than 50% complete. The Company expects to recognize all of its remaining performance obligations as revenue within the next thirty-six months.

10

Table of Contents

We are dependent each year on a small number of customers who generate a significant portion of our business, and these customers change from year to year. The following table sets forth revenue from customers who accounted for 10% or more of our revenue.

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three months ended | ​ | Three months ended | ​ | Nine months ended | ​ | Nine months ended | ​
​ | ​ | December 31, 2024 | ​ | December 31, 2023 |  | December 31, 2024 | ​ | December 31, 2023 | ​
Customer |  | Amount |  | Percent |  | Amount |  | Percent |  | Amount |  | Percent |  | Amount |  | Percent |
A | ​ | $ | 1,109 |  | 15 | % | $ | 1,904 |  | 25 | % | $ | 4,173 | ​ | 17 | % | $ | 6,750 | ​ | 29 | %
B | ​ | $ | 794 |  | 10 | % | $ | 1,176 |  | 15 | % | $ | 2,684 | ​ | 11 | % | $ | 2,488 | ​ | 11 | %
C | ​ | $ | 1,107 |  | 15 | % | $ | 915 |  | 12 | % | $ | 3,388 | ​ | 14 | % | $ | 2,357 | ​ | 10 | %
D | ​ | $ | * | ​ | * | % | $ | 911 | ​ | 12 | % | $ | * | ​ | * | % | $ | 2,321 | ​ | 10 | %
E | ​ | $ | 1,611 | ​ | 21 | % | $ | 1,329 | ​ | 17 | % | $ | 4,849 | ​ | 20 | % | $ | 3,430 | ​ | 15 | %
F | ​ | $ | 1,673 | ​ | 22 | % | $ | * | ​ | * | % | $ | 4,665 | ​ | 19 | % | $ | * | ​ | * | %
G | ​ | $ | * | ​ | * | % | $ | * | ​ | * | % | $ | * | ​ | * | % | $ | * | ​ | * | %
H | ​ | $ | * | ​ | * | % | $ | * | ​ | * | % | $ | * | ​ | * | % | $ | * | ​ | * | %
I | ​ | $ | * | ​ | * | % | $ | * | ​ | * | % | $ | * | ​ | * | % | $ | * | ​ | * | %

*Less than 10% of total

In our condensed consolidated balance sheet, contract assets and contract liabilities are reported in a net position on a contract-by-contract basis at the end of each reporting period. Contract assets consist of the following at:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | Progress | ​ | ​ | ​
​ |  | Unbilled |  | payments |  | Total
December 31, 2024 | ​ | $ | 23,797 | ​ | $ | (15,380) | ​ | $ | 8,417
March 31, 2024 | ​ | $ | 19,255 | ​ | $ | (10,728) | ​ | $ | 8,527

​

For the nine months ended December 31, 2024 and 2023, we recognized revenue of $2,103 and $1,195 related to our contract liabilities as of April 1, 2024 and 2023. Contract liabilities consist of the following as of:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ | ​ |  | Customer |  |  | ​
​ | ​ | Deferred Revenue | ​ | Deposits | ​ | Total
December 31, 2024 | ​ | $ | 1,036 | ​ | $ | 1,631 | ​ | $ | 2,667
March 31, 2024 | ​ | $ | 2,104 | ​ | $ | 1,684 | ​ | $ | 3,788

​

​

NOTE 4 – INCOME TAXES

The tax provision for interim periods is determined using the estimated annual effective consolidated tax rate, based on the current estimate of full-year earnings before taxes, adjusted for the impact of discrete quarterly items.

In assessing the recoverability of deferred tax assets, we consider whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. We have determined that it is more likely than not that certain future tax benefits may not be realized. The assessment was based on the weight of negative evidence at the balance sheet date, our recent operating losses and unsettled circumstances that, if unfavorably resolved, would adversely affect future operations and profit levels. Accordingly, a valuation allowance has been recorded against deferred tax assets that are unlikely to be realized. Realization of deferred tax assets will depend on the generation of sufficient taxable income in the appropriate jurisdictions, the reversal of deferred tax liabilities, tax planning strategies and other factors prior to the expiration date of the carryforwards. A change in the estimates used to make this determination could require an increase or a reduction the valuation allowance currently recorded against those deferred tax assets. The valuation allowance on deferred tax assets was approximately $6,200 on December 31, 2024 and $5,300 on March 31, 2024. We believe that it is more likely than not that the benefit from certain NOL carryforwards and other deferred tax assets will not be realized.

11

Table of Contents

For the three months ended December 31, 2024, there was no change in our judgment about the realizability of deferred tax assets in future years, and, therefore, no expense or benefit provided for income taxes. We recorded an income tax benefit for the three ($241) and nine months ($564) ended December 31, 2023. The Company’s effective tax rate for the nine months ended December 31, 2023 was 22.7%.

​

NOTE 5 – EARNINGS PER SHARE (EPS)

Basic EPS is computed by dividing reported earnings available to stockholders by the weighted average number of shares outstanding. Diluted EPS also includes the effect of stock options and restricted stock that would be dilutive. The following table provides a reconciliation of the numerators and denominators reflected in the basic and diluted earnings per share computations for the periods ended:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three Months ended |  | Three Months ended |  | Nine Months ended |  | Nine Months ended | ​
​ | ​ | December 31, 2024 | ​ | December 31, 2023 | ​ | December 31, 2024 | ​ | December 31, 2023 | ​
Basic and diluted EPS | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net loss | ​ | $ | (799) | ​ | $ | (865) | ​ | $ | (2,860) | ​ | $ | (1,921) | ​
Weighted average shares – basic and diluted | ​ |  | 9,607,785 | ​ | ​ | 8,759,171 | ​ | ​ | 9,389,346 | ​ | ​ | 8,698,034 | ​
Net loss per share | ​ | $ | (0.08) | ​ | $ | (0.10) | ​ | $ | (0.30) | ​ | $ | (0.22) | ​

​

​

The following table depicts all potential common stock equivalents that have an anti-dilutive effect are excluded from the calculation of diluted EPS (i.e., those that increase income per share or decrease loss per share), for the periods ended:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three Months ended |  | Three Months ended |  | Nine Months ended |  | Nine Months ended
​ | ​ | December 31, 2024 | ​ | December 31, 2023 | ​ | December 31, 2024 | ​ | December 31, 2023
Stock options |  | 542,500 |  | 542,500 |  | 542,500 |  | 542,500
Warrants |  | 566,783 |  | 25,000 |  | 566,783 |  | 25,000
Restricted stock |  | 55,000 |  | — |  | 55,000 |  | —

​

​

NOTE 6 – STOCK-BASED COMPENSATION

The 2016 TechPrecision Equity Incentive Plan, or the “2016 Plan”, is designed to reflect our commitment to having best practices in both compensation and corporate governance. The 2016 Plan provides for a share reserve of 1,250,000 shares of common stock.

The 2016 Plan authorizes the award of incentive and non-qualified stock options, restricted and unrestricted stock awards, restricted stock units, and performance awards to employees, directors, consultants, and other individuals who provide services to TechPrecision or its affiliates. The purpose of the 2016 Plan is to: (a) enable TechPrecision and its affiliated companies to recruit and retain highly qualified employees, directors and consultants; (b) provide those employees, directors and consultants with an incentive for productivity; and (c) provide those employees, directors and consultants with an opportunity to share in the growth and value of the Company. Subject to adjustment as provided in the 2016 Plan, the maximum number of shares of common stock that may be issued with respect to awards under the 2016 Plan is 1,250,000 shares (inclusive of awards issued under the 2006 Long-Term Incentive Plan, or the “2006 Plan”, that remained outstanding as of the effective date of the 2016 Plan). Shares of our common stock subject to awards that expire unexercised or are otherwise forfeited shall again be available for awards under the 2016 Plan.

As of December 31, 2024, there were 214,207 shares available for grant under the 2016 Plan. The following table summarizes information about options granted during the most recently completed periods:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Weighted
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Average
​ | ​ | ​ | ​ | Weighted | ​ | Aggregate | ​ | Remaining
​ | ​ | Number Of | ​ | Average | ​ | Intrinsic | ​ | Contractual Life
​ |  | Options |  | Exercise Price |  | Value |  | (in years)
Outstanding, vested, and exercisable at March 31, 2024 | ​ | 542,500 | ​ | $ | 1.53 | ​ | $ | 1,129 | ​ | 2.93
Outstanding, vested, and exercisable at December 31, 2024 | ​ | 542,500 | ​ | $ | 1.53 | ​ | $ | 1,151 | ​ | 2.28

​

12

Table of Contents

The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the closing stock price on the last trading day of the third quarter of fiscal 2025 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options as of December 31, 2024. This amount changes based on the fair market value of the Company’s common stock. The maximum contractual term is ten years for option grants. Other information relating to stock options outstanding as of December 31, 2024 is as follows:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | Weighted | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Options |  | Average |  | Options o/s |  | Exercisable
​ | ​ | Outstanding |  | Remaining |  | Weighted |  | Weighted
​ | ​ | And |  | Contractual | ​ | Average | ​ | Average
Range of Exercise Prices: |  | Exercisable |  | Term |  | Exercise Price |  | Exercise Price
$0.01-$0.99 |  | 192,500 |  | 0.61 | ​ | $ | 0.32 | ​ | $ | 0.32
$2.00-$2.99 |  | 350,000 |  | 2.42 | ​ | $ | 2.19 | ​ | $ | 2.19
Total |  | 542,500 |  | ​ | ​ |  |  | ​ |  |

​

Restricted Stock Awards

On August 3, 2023, we issued 15,000 shares of restricted common stock to our principal financial officer. Under the terms of the employment agreement, provided employment with the Company continues from the grant date through the applicable vesting dates, 5,000 shares of the restricted stock will vest on each of the first, second, and third anniversaries of the effective employment date of July 17, 2023. Fair value of $111 was measured on the date of grant based on the number of shares expected to vest and the quoted market price of the Company’s common stock. Stock-based compensation expense will be recognized ratably over the vesting period. Total recognized compensation cost related to this award for the nine months ended December 31, 2024, was $28. On December 31, 2024, there was $83 of remaining unrecognized compensation cost related to this award which is expected to be recognized over the next eighteen months.

​

On November 26, 2024, we issued 45,000 shares of restricted common stock to our principal financial officer. Under the terms of the employment agreement, provided employment with the Company continues from the grant date through the applicable vesting dates, 15,000 shares of the restricted stock will vest on each of the first, second, and third anniversaries of the effective employment date of September 30, 2024. Fair value of $149 was measured on the date of grant based on the number of shares expected to vest and the quoted market price of the Company’s common stock. Stock-based compensation expense will be recognized ratably over the vesting period. Total recognized compensation cost related to this award for the nine months ended December 31, 2024, was $12. Employment ended in February 2025. As such, all of the shares will be canceled and returned to the pool of shares authorized for issuance under the 2016 stock option plan. As of December 31, 2024, there was $8 of unrecognized compensation cost related to this award.

​

NOTE 7 - CONCENTRATION OF CREDIT RISK

We maintain bank account balances, which, at times, may exceed insured limits. We have not experienced any losses with these accounts and believe that we are not exposed to any significant credit risk on cash.

As of December 31, 2024, there were trade accounts receivable balances outstanding from two customers comprising 57% of the total trade receivables balance. The following table sets forth information as to trade accounts receivable from customers who accounted for 10% or more than our accounts receivable balance as of:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | December 31, 2024 | ​ | March 31, 2024 |
Customer |  | Amount |  | Percent |  | Amount |  | Percent |
A | ​ | $ | * |  | * | % | $ | 383 |  | 16 | %
B | ​ | $ | * |  | * | % | $ | * |  | * | %
C | ​ | $ | * |  | * | % | $ | * |  | * | %
D | ​ | $ | * |  | * | % | $ | * |  | * | %
E | ​ | $ | 859 |  | 44 | % | $ | 1,042 |  | 44 | %
F | ​ | $ | * |  | * | % | $ | * |  | * | %
G | ​ | $ | * |  | * | % | $ | * |  | * | %
H | ​ | $ | * |  | * | % | $ | 423 |  | 18 | %
I | ​ | $ | 247 | ​ | 13 | % | $ | * | ​ | * | %

*less than 10% of total

​

13

Table of Contents

NOTE 8 - OTHER CURRENT ASSETS

​

​ | ​ | ​ | ​ | ​ | ​ | ​
Other current assets included the following as of: |  | December 31, 2024 |  | March 31, 2024
Prepaid insurance | ​ | $ | 144 | ​ | $ | 337
Prepaid subscriptions | ​ |  | 88 | ​ |  | 120
Prepaid taxes | ​ |  | 70 | ​ |  | 27
Supplier advances | ​ | ​ | 11 | ​ | ​ | 26
Prepaid interest and deposits | ​ | ​ | 58 | ​ | ​ | 20
Other | ​ |  | 4 | ​ | ​ | 34
Total | ​ | $ | 375 | ​ | $ | 564

​

​

NOTE 9 - PROPERTY, PLANT AND EQUIPMENT, NET

​

​ | ​ | ​ | ​ | ​ | ​ | ​
Property, plant and equipment included the following as of: |  | December 31, 2024 |  | March 31, 2024
Land | ​ | $ | 110 | ​ | $ | 110
Building and improvements | ​ |  | 3,294 | ​ | ​ | 3,294
Machinery equipment, furniture, and fixtures | ​ |  | 24,702 | ​ | ​ | 25,591
Construction-in-progress | ​ |  | 1,199 | ​ | ​ | 148
Total property, plant, and equipment | ​ |  | 29,305 | ​ | ​ | 29,143
Less: accumulated depreciation | ​ |  | (15,842) | ​ | ​ | (14,345)
Total property, plant and equipment, net | ​ | $ | 13,463 | ​ | $ | 14,798

​

For the nine months ended December 31, 2024 and 2023, we recorded depreciation expense of $1,565 and $1,248, respectively.

In September 2023, the Company signed an agreement to make additional equipment upgrades for a certain customer. We recognize new purchases as a fixed asset and billings for reimbursement from the customer as a contra-asset. Future depreciation of the asset will be offset directly by the amortization of the contra-asset on a net basis in the statement of operations. The amortization period will match the schedule of depreciation set forth under our policies.

​

NOTE 10 - ACCRUED EXPENSES

​

​ | ​ | ​ | ​ | ​ | ​ | ​
Accrued expenses included the following as of: |  | December 31, 2024 |  | March 31, 2024
Accrued compensation | ​ | $ | 1,018 | ​ | $ | 1,172
Provision for claims | ​ | ​ | 248 | ​ | ​ | 517
Provision for contract losses | ​ |  | 479 | ​ | ​ | 293
Accrued professional fees | ​ |  | 402 | ​ | ​ | 459
Accrued project costs | ​ |  | 907 | ​ | ​ | 560
Accrued breakup fee | ​ | ​ | — | ​ | ​ | 1,117
Accrued liquidated damages | ​ | ​ | 108 | ​ | ​ | —
Other | ​ |  | 182 | ​ | ​ | 145
Total | ​ | $ | 3,344 | ​ | $ | 4,263

​

Accrued compensation includes amounts for executive bonuses, payroll and vacation and holiday pay. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in the provision are recorded in cost of revenue. Accrued project costs are estimates for certain project expenses during the reporting period.

Due to a change in certain conditions and events, it became probable that on March 31, 2024, the Company would not be able to close on the acquisition of Votaw Precision Technologies, Inc. and accrued a breakup fee of $1,117. On April 29, 2024, we issued 320,000 shares of common stock with a fair value of $1,536 for the breakup fee payment as set forth under the terms and conditions of the agreement. The additional $419 was based on the change in fair value of shares at the time of issuance was recorded in April 2024.

​

14

Table of Contents

NOTE 11 – DEBT

​

​ | ​ | ​ | ​ | ​ | ​ | ​
Debt included the following loans as of: |  | December 31, 2024 |  | March 31, 2024
Stadco Term Loan, at 3.79% interest, due August 2028 | ​ | $ | 2,229 | ​ | $ | 2,647
Ranor Term Loan, at 6.05% interest, due December 2027 | ​ | ​ | 2,168 | ​ | ​ | 2,216
Ranor Revolver Loan, due April 2025 | ​ | ​ | 2,930 | ​ | ​ | 2,785
Stadco equipment financing, at 13.38% interest, due September 2026 | ​ | ​ | 50 | ​ | ​ | —
Total debt | ​ | $ | 7,377 | ​ | $ | 7,648
Less: debt issue costs unamortized | ​ | $ | 80 | ​ | $ | 89
Total debt, net | ​ | $ | 7,297 | ​ | $ | 7,559
Less: Current portion of long-term debt | ​ | $ | 7,278 | ​ | $ | 7,559
Total long-term debt, net | ​ | $ | 19 | ​ | $ | —

​

Amended and Restated Loan Agreement

On August 25, 2021, the Company entered into an amended and restated loan agreement with Berkshire Bank, or the “Loan Agreement”. Under the Loan Agreement, Berkshire Bank will continue to provide the Ranor Term Loan (as defined below) and the revolving line of credit, or the “Revolver Loan”. In addition, Berkshire Bank provided the Stadco Term Loan (as defined below) in the original amount of $4,000. The proceeds of the original Ranor Term Loan of $2,850 were previously used to refinance existing mortgage debt of Ranor. The proceeds of the Revolver Loan are used for working capital and general corporate purposes of the Company. The proceeds of the Stadco Term Loan were used to support the acquisition of Stadco and refinance existing indebtedness of Stadco.

Stadco Term Loan

On August 25, 2021, Stadco borrowed $4,000 from Berkshire Bank, or the “Stadco Term Loan”, under the Loan Agreement. Interest on the Stadco Term Loan is due on unpaid balances beginning on August 25, 2021 at a fixed rate per annum equal to the 7 year Federal Home Loan Bank of Boston Classic Advance Rate plus 2.25%. Since September 25, 2021 and on the 25th day of each month thereafter, Stadco has made and will continue to make monthly payments of principal and interest in the amount of $54, with all remaining outstanding principal and accrued interest due and payable on August 25, 2028. Interest shall be calculated based on actual days elapsed and a 360-day year.

Unamortized debt issue costs as of December 31, 2024, and March 31, 2024 were $21 and $30, respectively.

Ranor Term Loan and Revolver Loan

A term loan was made to Ranor by Berkshire Bank in 2016 in the amount of $2,850, or the “Ranor Term Loan”. Payments began on January 20, 2017, and were made in monthly installments of $19, inclusive of interest at a fixed rate of 5.21% per annum, with all outstanding principal and accrued interest due and payable on the original maturity date, December 20, 2021.

Since December 2021, Ranor and certain affiliates of the Company entered into nine separate amendments to the Amended and Restated Loan Agreement and Promissory Note to extend the maturity date of the Ranor Term Loan and Revolver Loan to December 15, 2027 and January 15, 2025, respectively.

On December 20, 2023, Ranor and certain affiliates of the Company entered into a Sixth Amendment to Amended and Restated Loan Agreement and Second Amendment to Second Amended and Restated Promissory Note, or the “Sixth Amendment”. Effective December 20, 2023, the Sixth Amendment, among other things (i) extended the maturity date of the Revolver Loan from December 20, 2023 to March 20, 2024; (ii) limited the use of proceeds from the Revolver Loan by the Company or its affiliates to $1,000 in the aggregate for due diligence and related professional costs incurred on or prior to March 20, 2024 in connection with any acquisitions; and (iii) makes certain changes to the amount and methods of valuation of equipment securing repayment of the borrowed funds.

On March 20, 2024, Ranor and certain affiliates of the Company entered into a Seventh Amendment to Amended and Restated Loan Agreement and Third Amendment to Second Amended and Restated Promissory Note, or the “Seventh Amendment”. Effective March 20, 2024, the Seventh Amendment, among other things (i) extended the maturity date of the Revolver Loan from March 20, 2024 to May 20, 2024; (ii) limited the use of proceeds from the Revolver Loan by the Company or its affiliates to $2,000 in the aggregate for due diligence and related professional costs incurred on or prior to May 10, 2024 in connection with any acquisitions; and (iii) makes certain changes to the amount and methods of valuation of equipment securing repayment of the borrowed funds. Through May 20,

15

Table of Contents

2024, Ranor utilized a revolving line of credit with, following certain modifications, a maximum principal amount available of $5,000. Advances under the Revolver Loan are subject to a borrowing base equal to the lesser of (a) $5,000 or (b) the sum of (i) 80% of the net outstanding amount of Base Accounts, plus (ii) the lesser of (x) 25% of Eligible Raw Material Inventory, and (y) $250, plus (iii) 80% of the Appraised Value of the Eligible Equipment, as such terms are defined in the Loan Agreement.

On May 28, 2024, Ranor and the other Borrowers entered into an Eighth Amendment to Amended and Restated Loan Agreement and Fourth Amendment to Second Amended and Restated Promissory Note with Berkshire Bank. Effective May 24, 2024, the Eighth Amendment, among other things, (i) extended the maturity date of the Revolver Loan from May 24, 2024 to August 30, 2024; (ii) amended the maximum principal amount of the Revolver Loan from $5,000 to $4,500; and (iii) effective on June 1, 2024, increases the Term SOFR Margin (as defined in the Amendment) used to calculate the interest rate from 2.25% per annum to 2.50% per annum.

On September 4, 2024, Ranor and the other Borrowers entered into a Ninth Amendment to Amended and Restated Loan Agreement and Fifth Amendment to Second Amended and Restated Promissory Note, or the “Ninth Amendment”, with Berkshire Bank. Effective August 30, 2024, the Ninth Amendment, among other things, extended the maturity date of the Revolver Loan from August 30, 2024 to January 15, 2025.

On December 19, 2024, Ranor and the other Borrowers entered into a Tenth Amendment to Amended and Restated Loan Agreement and Sixth Amendment to Second Amended and Restated Promissory Note, or the “Tenth Amendment”, with Berkshire Bank. The Tenth Amendment, among other things, extended the maturity date of the Revolver Loan from January 15, 2025 to April 30, 2025.

The Company agrees to pay to Berkshire Bank, as consideration for Berkshire Bank’s agreement to make the Revolver Loan available, a nonrefundable Revolver Loan fee equal to 0.25% per annum (computed based on a year of 360 days and actual days elapsed) on the difference between the amount of: (a) $5,000, and (b) the average daily outstanding balance of the Revolver Loan during the quarterly period then ended. All Revolver Loan fees are payable quarterly in arrears on the first day of each January, April, July and October and on the Revolver Maturity Date, or upon acceleration of the Revolver Loan, if earlier. Interest-only payments on advances made under the Revolver Loan will continue to be payable monthly in arrears. Under the amended promissory note for the Revolver Loan, the Company pays interest at the Term SOFR-based rate.

Paid and accrued interest expense under the Revolver Loan during the nine months ended December 31, 2024 and 2023 was $146 and $117, respectively. The weighted average interest rate as of December 31, 2024 and March 31, 2024 was 7.81% and 7.60%, respectively. The weighted average amount outstanding during the nine months ended December 31, 2024 was $2,286. There was $2,930 outstanding under the Revolver Loan as of December 31, 2024. Unused borrowing capacity as of December 31, 2024 and March 31, 2024 was approximately $165 and $539, respectively.

Unamortized debt issue costs as of December 31, 2024 and March 31, 2024 were $59 and $59, respectively.

Berkshire Loan Covenants

For purposes of this discussion, Ranor and Stadco are referred to together as the “Borrowers”. The Ranor Term Loan, the Stadco Term Loan and the Revolver Loan, or together, the “Berkshire Loans”, may be accelerated upon the occurrence of an event of default as defined in the Loan Agreement. Upon the occurrence and during the continuance of certain default events, at the option of Berkshire Bank, or automatically without notice or any other action upon the occurrence of certain other events specified in the Loan Agreement, the unpaid principal amount of the Berkshire Loans together with accrued interest and all other obligations owing by the Borrowers to Berkshire Bank would become immediately due and payable without presentment, demand, protest, or further notice of any kind.

16

Table of Contents

The Company agreed to maintain compliance with certain financial covenants under the Loan Agreement. Namely, the Borrowers agree to maintain the ratio of the Cash Flow of TechPrecision-to-the Total Debt Service of TechPrecision of not less than 1.20 to 1.00, measured quarterly on the last day of each fiscal quarter, or annual period of TechPrecision on a trailing 12-month basis. Calculations will be based on the audited (year-end) and unaudited (quarterly) consolidated financial statements of TechPrecision. Quarterly tests will be measured based on the financial statements included in the Company’s quarterly reports on Form 10-Q within 60 days of the end of each quarter, and annual tests will be measured based on the financial statements included in the Company’s annual reports on Form 10-K within 120 days after the end of each fiscal annual period. Cash Flow means an amount, without duplication, equal to the sum of net income of TechPrecision plus (i) interest expense, plus (ii) taxes, plus (iii) depreciation and amortization, plus (iv) stock based compensation expense taken by TechPrecision, plus (v) non-cash losses and charges and one time or non-recurring expenses at Berkshire Bank’s discretion, less (vi) the amount of cash distributions, if any, made to stockholders or owners of TechPrecision, less (vii) cash taxes paid by the TechPrecision, all as determined in accordance with U.S. GAAP. “Total Debt Service” means an amount, without duplication, equal to the sum of (i) all amounts of cash interest paid on liabilities, obligations, and reserves of TechPrecision paid by TechPrecision, (ii) all amounts paid by TechPrecision in connection with current maturities of long-term debt and preferred dividends, and (iii) all payments on account of capitalized leases, all as determined in accordance with U.S. GAAP.

The Borrowers agree to cause their Balance Sheet Leverage to be less than or equal 2.50 to 1.00. For purposes of this covenant, “Balance Sheet Leverage” means, at any date of determination, the ratio of Borrowers’ (a) Total Liabilities, less Subordinated Debt, to (b) Net Worth, plus Subordinated Debt.

The Borrowers agree to maintain a Loan-to-Value Ratio of not greater than 0.75 to 1.00. “Loan-to-Value Ratio” means the ratio of (a) the sum of the outstanding balance of the Ranor Term Loan and the Stadco Term Loan to (b) the fair market value of the property pledged as collateral for the loan, as determined by an appraisal obtained from time to time by Berkshire Bank, but not more frequently than one time during each 365 day period (provided that Berkshire Bank may obtain an appraisal at any time after either the Ranor Term Loan or the Stadco Term Loan has been accelerated), which appraisals shall be at the expense of the Borrowers.

The Borrowers agree that their combined annual capital expenditures shall not exceed $1,500, subject to certain agreed-upon exclusions. Compliance is tested annually.

On June 12, 2023, the Company and Berkshire Bank executed a waiver under which Berkshire Bank waived the Company’s noncompliance with the capital expenditure limit on March 31, 2023. The waiver document also contained an agreement by the parties to exclude from the calculation of capital expenditures for purposes of the Loan Agreement during the year ending March 31, 2024, any such expenditures made by the Company to the extent they are made using funds provided by customers of the Company for the purpose of making such capital expenditures.

The Company was not in compliance with the debt service and balance sheet leverage tests as of December 31, 2024. It is also probable that the Company will not be in compliance with the same debt covenants at subsequent measurement dates within the next twelve months. As a result of the above, all of our long-term debt has been classified as current in our consolidated balance sheet.

Collateral securing all the above obligations comprises all personal and real property of the Company, including cash, accounts receivable, inventories, equipment, and financial assets. The carrying value of short and long-term borrowings approximates their fair value. The Company’s short-term and long-term debt is all privately held with no public market for this debt and is considered to be Level 3 under the fair value hierarchy.

Stadco Equipment Financing

Stadco entered into a two year equipment financing agreement dated May 1, 2024 to purchase certain computer hardware for $65. Since October 2024 and on the last day of each month thereafter, Stadco has made and will continue to make monthly payments of $3, with all remaining outstanding amounts due and payable on April 30, 2026. The obligation under this agreement on December 31, 2024 totals $50 and is classified under the current portion of long-term debt in the condensed consolidated balance sheet.

​

​

NOTE 12 - OTHER NONCURRENT LIABILITIES

Under an addendum to a contract purchase order, one of our customers agreed to reimburse the Company for the cost of certain new equipment. Payments are received as the Company’s incurs construction costs. All payments were received under this contract during the fiscal years ended March 31, 2024, 2023 and 2022. In case of a contract breach, at the time of the breach, the customer may claw

17

Table of Contents

back the funds based on a prorated ten-year straight-line annual declining balance recovery period. This liability amount is included in the Company’s condensed consolidated balance sheets as a noncurrent liability.

In September 2023, we signed an agreement to purchase new equipment for another customer who agreed to reimburse the Company for the cost of the equipment. We received the first payment in fiscal 2024, with additional payments received during the nine months ended December 31, 2024. Advance payments from the customer accrue in the Company’s condensed consolidated balance sheets as a noncurrent liability.

On December 31, 2024 and March 31, 2024, a sum total of $3,235 and $3,528 was included in other noncurrent liabilities under the programs described above.

In fiscal year 2023, Stadco entered into the Payment Agreement with the Los Angeles Department of Water and Power, or “LADWP”, to settle previously outstanding amounts for water, water service, electric energy and/or electric service in the aggregate amount of $1,800 that were delinquent and unpaid. Under the Payment Agreement, Stadco will make monthly installment payments on the unpaid balance beginning on December 15, 2022, in an aggregate amount of $18 per month until the earlier of November 15, 2030, or the amount due is paid in full. Late payments under the Payment Agreement accrue a late payment charge equal to an 18% annual rate on the unpaid balance. This liability amount was included in the Company’s balance sheet as a current and noncurrent liability as of December 31, 2024 and March 31, 2024 for $221 and $1,088, and $221 and $1,254, respectively.

NOTE 13 – LEASES

On August 25, 2021, Stadco became party to an amended building and property operating lease and recorded a right of use asset and liability of $6,694. Monthly base rent for the property is $83 per month. The term of the lease will expire on June 30, 2030, and the lessee has no right of renewal beyond the expiration date. The lease contains customary default provisions allowing the landlord to terminate the lease if the lessee fails to remedy a breach of its obligations under the lease within the period specified in the lease, or upon certain events of bankruptcy or seizure or attachment of the lessee’s assets or interest in the lease. The lease also contains other customary provisions for real property leases of this type.

The following table lists our right-of-use assets and liabilities on our condensed consolidated balance sheets as of:

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | December 31, 2024 |  | March 31, 2024
Right of Use Asset |  | ​ | ​ | ​ | ​ |
Right of use asset – operating lease | ​ | $ | 6,629 | ​ | $ | 6,629
Right of use asset – finance leases | ​ | ​ | 65 | ​ | ​ | 65
Accumulated amortization | ​ | ​ | (2,245) | ​ | ​ | (1,717)
Right of use assets net | ​ | $ | 4,449 | ​ | $ | 4,977
Lease liability – operating lease | ​ | $ | 4,583 | ​ | $ | 5,125
Lease liability – finance leases | ​ | ​ | 12 | ​ | ​ | 19
Total lease liability | ​ | $ | 4,595 | ​ | $ | 5,144

​

18

Table of Contents

Other supplemental information regarding our leases is contained in the following tables:

​

​ | ​ | ​ | ​ | ​ | ​ | ​
Components of lease expense for the nine months ended: |  | December 31, 2024 |  | December 31, 2023
Operating lease amortization | ​ | $ | 522 | ​ | $ | 498
Finance lease amortization | ​ | $ | 6 | ​ | $ | 13
Finance lease interest | ​ | $ | — | ​ | $ | 1

​

​ | ​ | ​ | ​ | ​ | ​
Weighted average lease term and discount rate at: |  | December 31, 2024 |  | December 31, 2023 |
Lease term (years) – operating lease |  | 5.50 | ​ | 6.50 | ​
Lease term (years) – finance lease | ​ | 1.25 | ​ | 2.25 | ​
Lease rate – operating lease | ​ | 4.5 | % | 4.5 | %
Lease rate – finance lease |  | 3.2 | % | 3.2 | %

​

​

​ | ​ | ​ | ​ | ​ | ​ | ​
Supplemental cash flow information related to leases for the nine months ended: |  | December 31, 2024 |  | December 31, 2023
Cash used in operating activities | ​ | $ | 704 | ​ | $ | 704
Cash used in financing activities | ​ | $ | 7 | ​ | $ | 15

​

Maturities of lease liabilities on December 31, 2024 for the next five years and thereafter:

​

​ | ​ | ​ | ​
January 1, 2025 – December 31, 2025 |  | $ | 948
January 1. 2026 – December 31, 2026 | ​ |  | 941
January 1, 2027 – December 31, 2027 | ​ |  | 939
January 1, 2028 – December 31, 2028 | ​ |  | 939
January 1, 2029 – December 31, 2029 | ​ | ​ | 939
Thereafter | ​ |  | 391
Total lease payments | ​ | $ | 5,097
Less: imputed interest | ​ |  | 502
Total | ​ | $ | 4,595

​

​

​

NOTE 14 – COMMITMENTS

Purchase Commitments

As of December 31, 2024, we had approximately $7,349 in purchase obligations outstanding, which primarily consisted of contractual commitments to purchase new materials and supplies.

Retirement Benefits

The Company has two defined contribution and savings plan that covers substantially all employees who have completed 90 days of service. The Company contributed the following amounts to the plan during the periods ended:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three Months ended |  | Three Months ended |  | Nine Months ended |  | Nine Months ended
​ | ​ | December 31, 2024 | ​ | December 31, 2023 | ​ | December 31, 2024 | ​ | December 31, 2023
Company contributions | ​ | $ | 21 | ​ | $ | 21 | ​ | $ | 63 | ​ | $ | 64

​

Legal Proceeding

The estimated amounts of liabilities recorded for pending and threatened litigation are recorded in other current liabilities in our consolidated balance sheets. In accordance with the accounting standard for contingencies, we record a liability when management believes that it is both probable that a liability has been incurred and we can reasonably estimate the amount of the loss. Generally, the loss is recorded for the amount we expect to resolve the liability. We believe we have recorded adequate provisions for our litigation matters. We review and adjust these provisions quarterly to reflect the effect of negotiations, settlements, rulings, and advice.

On October 30, 2023, a former employee filed suit against Stadco asserting individual wage and hour claims, claims for age and disability discrimination under California law, and a collective action on behalf of all non-exempt Stadco employees pursuant to the California Private Attorneys General Act of 2004 (“PAGA”) [Cal. Lab. Code, ss. 2698, et seq.], to impose civil penalties for certain violations of

19

Table of Contents

the California Labor Code. Stadco has retained outside legal counsel to defend this action. The case has been stayed and was resolved in principle at mediation on June 26, 2024. The former employee’s individual claims were also resolved at mediation, and final settlement payment on the individual claims was due and paid in August 2024.

On October 8, 2024, the Los Angeles County (CA) Superior Court approved the settlement of the Plaintiff’s claim for imposition of civil penalties pursuant to the PAGA. Under the terms of the PAGA Settlement Agreement, the full PAGA settlement amount was paid by Stadco on December 12, 2024, which was included in accrued expenses under the provision for claims as of March 31, 2024.

​

NOTE 15 – SEGMENT INFORMATION

The Company has two wholly owned subsidiaries, Ranor and Stadco that are reportable segments. All of the Company’s operations, assets, and customers are located in the U.S.

Each reportable segment focuses on the manufacture and assembly of specific components, primarily for defense, aerospace and other industrial customers. However, both segments have separate operating, engineering, and sales teams. Our Chief Executive Officer, or “CEO”, is the Chief Operating Decision Maker, or “CODM”, and evaluates the performance of our segments based upon, among other things, segment revenue and operating profit. Segment operating profit excludes general corporate costs. Corporate costs include executive and director compensation, stock-based compensation, and other corporate and administrative expenses not allocated to the segments. The following table provides summarized financial information for our segments:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended | ​ | Nine Months Ended
​ | ​ | December 31, | ​ | December 31,
​ |  | 2024 |  | 2023 |  | 2024 |  | 2023
Ranor | ​ | $ | 4,310 | ​ | $ | 4,296 | ​ | $ | 13,482 | ​ | $ | 13,291
Stadco | ​ |  | 3,312 | ​ | ​ | 3,370 | ​ | ​ | 11,139 | ​ | ​ | 9,943
Intersegment elimination | ​ | ​ | — | ​ | ​ | (16) | ​ | ​ | (67) | ​ | ​ | (243)
Revenue from external customers | ​ |  | 7,622 | ​ | ​ | 7,650 | ​ | ​ | 24,554 | ​ | ​ | 22,991
Ranor | ​ |  | 1,049 | ​ | ​ | 1,015 | ​ | ​ | 3,103 | ​ | ​ | 2,562
Stadco | ​ | ​ | (854) | ​ | ​ | (514) | ​ | ​ | (3,013) | ​ | ​ | (1,741)
Corporate and unallocated (1) | ​ | ​ | (891) | ​ | ​ | (1,497) | ​ | ​ | (2,615) | ​ | ​ | (2,994)
Total operating loss | ​ | ​ | (696) | ​ | ​ | (996) | ​ | ​ | (2,525) | ​ | ​ | (2,173)
Other income | ​ | ​ | 44 | ​ | ​ | — | ​ | ​ | 57 | ​ | ​ | 41
Interest expense | ​ |  | (147) | ​ | ​ | (110) | ​ | ​ | (392) | ​ | ​ | (353)
Consolidated loss before income taxes | ​ | $ | (799) | ​ | $ | (1,106) | ​ | $ | (2,860) | ​ | $ | (2,485)
Assets: | ​ |  | ​ | ​ |  | ​ | ​ | ​ | ​ | ​ | ​ | ​
Ranor | ​ | ​ | ​ | ​ | ​ | ​ | ​ | $ | 11,978 | ​ | $ | 11,973
Stadco | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 19,951 | ​ | ​ | 22,420
Corporate and unallocated | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 231 | ​ | ​ | 354
Totals | ​ | ​ | ​ | ​ | ​ | ​ | ​ | $ | 32,160 | ​ | $ | 34,747
Depreciation and amortization: | ​ |  | ​ | ​ |  | ​ | ​ | ​ | ​ | ​ | ​ | ​
Ranor | ​ | ​ | ​ | ​ | ​ | ​ | ​ | $ | 781 | ​ | $ | 481
Stadco | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | 1,312 | ​ |  | 1,278
Totals | ​ | ​ | ​ | ​ | ​ | ​ | ​ | $ | 2,093 | ​ | $ | 1,759
Capital expenditures | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ |  | ​
Ranor | ​ | ​ | ​ | ​ | ​ | ​ | ​ | $ | 2,727 | ​ | $ | 2,756
Stadco | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | 69 | ​ |  | 26
Totals | ​ | ​ | ​ | ​ | ​ | ​ | ​ | $ | 2,796 | ​ | $ | 2,782

(1) | Corporate general costs include executive and director compensation, and other corporate administrative expenses not allocated to the segments.

20

Table of Contents

NOTE 16 – SUBSEQUENT EVENT

Private Placement

On February 11. 2025, the Company received $498 in proceeds from the sale of the remaining shares of the Company’s common stock, and common stock purchase warrants in a private placement pursuant to a Securities Purchase Agreement with certain accredited investors which closed on July 8, 2024 (see Note 2, Basis of Presentation and Significant Accounting Policies).Pursuant to the Securities Purchase Agreement, we agreed to have a registration statement registering for resale the shares and the shares underlying the warrants declared effective with 60 days of the closing date. The registration statement was declared effective by the Securities and Exchange Commission on January 31, 2025. Since, the registration statement was not declared effective in a timely manner, the Company is obligated to pay approximately $108 as liquidated damages under the agreement, which is included in accrued expenses.

On January 24, 2024, pursuant to the 2016 Equity Incentive Plan, the Company awarded 54,880 shares, in the aggregate, of restricted common stock to our four non-employee directors. The restricted common stock shall vest and become nonforfeitable on December 19, 2025. During the period commencing on the grant date and ending on the vesting date, the grantee is not permitted to sell, transfer, pledge, assign or otherwise encumber the restricted common stock. The grantee must be serving as a director as of the vesting date and must have been continuously serving in such capacity from the grant date through the vesting date. Fair value of $180 was measured on the date of grant based on the number of shares expected to vest and the quoted market price of the Company’s common stock. Stock-based compensation expense will be recognized ratably over the vesting period.

​

​

21

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

(in thousands, except per share data)

Statement Regarding Forward Looking Disclosure

The following discussion of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and the related notes, which appear elsewhere in this Quarterly Report on Form 10-Q. This Quarterly Report on Form 10-Q, including this section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” may contain predictive or “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of current or historical fact contained in this quarterly report, including statements that express our intentions, plans, objectives, beliefs, expectations, strategies, predictions, or any other statements relating to our future activities or other future events, or conditions are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “will,” “should,” “would” and similar expressions, as they relate to us, are intended to identify forward-looking statements.

These forward-looking statements are based on current expectations, estimates and projections made by management about our business, our industry and other conditions affecting our financial condition, results of operations or business prospects. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in, or implied by, the forward-looking statements due to numerous risks and uncertainties. As discussed below under “Liquidity and Capital Resources”, certain events and conditions, when examined in the aggregate, indicate substantial doubt about our ability to continue as a going concern for at least one year beyond the date of the financial statements. Factors that could cause such outcomes and results to differ include, but are not limited to, risks and uncertainties arising from:

| ● | our reliance on individual purchase orders, rather than long-term contracts, to generate revenue;

| ● | our ability to balance the composition of our revenue and effectively control operating expenses;

| ● | external factors that may be outside of our control, including health emergencies, like epidemics or pandemics, California wildfires, the conflicts in Eastern Europe and the Middle East, price inflation, increasing interest rates, and supply-chain inefficiencies;

| ● | the availability of appropriate financing facilities impacting our operations, financial condition and/or liquidity;

| ● | our ability to receive contract awards through competitive bidding processes;

| ● | our ability to maintain standards to enable us to manufacture products to exacting specifications;

| ● | our ability to enter new markets for our services;

| ● | our reliance on a small number of customers for a significant percentage of our business;

| ● | competitive pressures in the markets we serve;

| ● | changes in the availability or cost of raw materials and energy for our production facilities;

| ● | restrictions in our ability to operate our business due to our outstanding indebtedness;

| ● | government tariffs, regulations and requirements;

| ● | pricing and business development difficulties;

| ● | changes in government spending on national defense;

| ● | our ability to make acquisitions and successfully integrate those acquisitions with our business;

| ● | our failure to maintain effective internal controls over financial reporting;

| ● | general industry and market conditions and growth rates,

| ● | those risks discussed in “Item 1A. Risk Factors” and elsewhere in our Annual Report on Form 10-K, as well as those described in any other filings which we make with the SEC.

22

Table of Contents

Any forward - looking statements speak only as of the date on which they are made, and we undertake no obligation to publicly update or revise any forward - looking statements to reflect events or circumstances that may arise after the date of this Quarterly Report on Form 10 - Q, except as required by applicable law. Investors should evaluate any statements made by us in light of these important factors.

Overview

TechPrecision, through our wholly owned subsidiaries, is a manufacturer of large - scale metal fabricated and machined precision components and equipment. These components are used in a variety of markets, primarily defense and aerospace, and secondarily precision industrial. All our operations and customers are in the United States.

We work with our customers to manufacture components in accordance with the customers’ drawings and specifications. Our work complies with specific military specifications and standards as well as national and international codes and standards required by our customers. We believe that we have earned our reputation through outstanding technical expertise, attention to detail, and a total commitment to quality and excellence in customer service.

The manufacturing operations of our Ranor subsidiary are situated on approximately 65 acres in North Central Massachusetts. Leveraging our 145,000 square foot facilities, Ranor provides a full range of custom solutions to transform material into precision finished welded components and precision finished machined components up to 100 tons: manufacturing engineering, materials management and traceability, high-precision heavy fabrication (in-house fabrication operations include cutting, press and roll forming, welding, heat treating, assembly, blasting and painting), heavy high-precision machining (in-house machining operations include CNC programming, finishing, and assembly), QC inspection including portable CMM, NonDestructive Testing, and final packaging.

All manufacturing at Ranor is performed in accordance with customer requirements. Ranor is an ISO 9001:2015 certificate holder. Ranor is a US defense-centric company with over 95% of its revenue in the defense sector. Ranor is registered and compliant with ITAR.

The manufacturing operations of our Stadco subsidiary are situated in an industrial self-contained multi-building complex comprised of approximately 183,000 square feet under roof in Los Angeles, California. Stadco manufactures large mission-critical components on several high-profile military aircraft, military helicopter, and military space programs. Stadco has been a critical supplier to a blue-chip customer base that includes some of the largest OEMs and prime contractors in the defense and aerospace industries. Stadco also manufactures tooling, molds, fixtures, jigs and dies used in the production of defense-centric aircraft components.

Our Stadco subsidiary, similar to Ranor, provides a full range of custom solutions: manufacturing engineering, materials management and traceability, high-precision fabrication (in-house fabrication operations include waterjet cutting, press forming, welding, and assembly) and high-precision machining (in-house machining operations include CNC programming, finishing, and assembly), QC inspection including both fixed and portable CMM NonDestructive Testing, and final packaging. In addition, Stadco features a large electron beam welding cell, and two NonDestructive Testing work cells, a unique mission-critical technology set.

All manufacturing at Stadco is performed in accordance with customer requirements. Stadco is an AS 9100 D and ISO 9001:2015 certificate holder and a NADCAP NonDestructive Testing certificate holder. Stadco is a US defense-centric company with almost all of its revenue in the defense sector. Stadco is registered and compliant with ITAR.

Custom Manufacturing

We manufacture a variety of components in accordance with our internal core competencies and external customer needs and requirements. We also provide manufacturing engineering services to assist customers in optimizing their engineering designs for manufacturability. We do not design the components we manufacture; we custom manufacture according to customer “build-to-print” requirements and specifications. Accordingly, we do not distribute the components that we manufacture on the open market, and we do not market any products. We do not own the intellectual property rights to any proprietary marketed product, and we do not manufacture in anticipation of orders. Our custom manufacturing operations do not commence on any project before we receive and accept a customer’s purchase order. We only accept contracts that cover specific components within the capability of our resources.

We primarily target repeating custom programs with relatively mature and stable designs in order to provide long-term solutions for our customers. The multi-unit work is repeat work or a single product with multiple quantity releases. Secondarily, our activities include a

23

Table of Contents

variety of both multi-unit and one-off requirements. The one-off work is typically either a prototype or a unique, one-of-a-kind component.

Changes in regulations and market demand for our manufacturing expertise can be significant and sudden, and require us to adapt to the needs of the customers that we serve Understanding this dynamic, we focus on the defense industry in order to reliably pivot with our defense customers to jointly develop the capability to transform our workforce to manufacture components in accordance with our own and our external customers’ changing requirements.

We primarily serve customers in the defense and aerospace; secondarily in the precision industrial sectors. Within these sectors, we have manufactured custom components for US Navy submarines and aircraft carriers, USMC military helicopters, US defense and civilian aerospace programs.

Our contracts are generated both through negotiation with the customer and from bids made pursuant to a request for proposal. Our ability to receive contract awards is dependent upon the contracting party’s perception of such factors as our ability to perform on time, our history of performance, including quality, our financial condition, and our ability to price our services competitively.

All the Company’s operations, assets, and customers are located in the U.S.

Recent Developments

Termination of Votaw Acquisition

On November 22, 2023 we and the Seller, entered into the Purchase Agreement, pursuant to which, we would acquire all of the issued and outstanding common stock of Votaw Precision Technologies, Inc. (“Votaw”) and after giving effect to such purchase, Votaw was to become our wholly owned subsidiary.

Due to a change in certain conditions and events, it became probable that on March 31, 2024, the Company would be unable to close on the acquisition. On April 2, 2024, the Seller delivered to the Company written notice of its election to terminate the Purchase Agreement under Section 7.01(f) effective immediately. Pursuant to Section 7.01(f) of the Purchase Agreement, in the event that the Closing had not occurred by March 31, 2024, either we or the Seller had the right to terminate the Purchase Agreement, subject to the party terminating having complied with the other required closing conditions.

Since the Seller validly terminated the Purchase Agreement pursuant to Section 7.01(f), the Company was required to pay to the Seller the Stock Termination Fee. Under the Purchase Agreement, the Stock Termination Fee can increase by 48,000 additional shares of the Company’s common stock under certain conditions, including if the Company fails to use commercially reasonable efforts to cause a registration statement to effect the resale of the shares of common stock composing the Stock Termination Fee to be declared effective by the Securities and Exchange Commission as soon as practicable. Such registration statement was filed with the Securities and Exchange Commission on May 2, 2024, and declared by the Securities and Exchange Commission, on January 31, 2025.

On April 29, 2024, we issued 320,000 shares of our common stock as the Stock Termination Fee.

Amendments to Amended and Restated Loan Agreement and to Second Amended and Restated Promissory Note

On May 28, 2024, Ranor and the other Borrowers entered into an Eighth Amendment to Amended and Restated Loan Agreement and Fourth Amendment to Second Amended and Restated Promissory Note, or the “Eighth Amendment”, with Berkshire Bank. Effective May 24, 2024, the Eighth Amendment, among other things, (i) extends the maturity date of the Revolver Loan from May 24, 2024 to August 30, 2024; (ii) amends the maximum principal amount of the Revolver Loan from $5,000 to $4,500; and (iii) effective on June 1, 2024, increases the Term SOFR Margin (as defined in the Amendment) used to calculate the interest rate from 2.25% per annum to 2.50% per annum.

24

Table of Contents

On September 4, 2024, Ranor and the other Borrowers entered into a Ninth Amendment to Amended and Restated Loan Agreement and Fifth Amendment to Second Amended and Restated Promissory Note, or the “Ninth Amendment”, with Berkshire Bank. Effective August 30, 2024, the Ninth Amendment, among other things, (i) extends the maturity date of the Revolver Loan from August 30, 2024 to January 15, 2025.

On December 19, 2024, Ranor and the other Borrowers entered into a Tenth Amendment to Amended and Restated Loan Agreement and Sixth Amendment to Second Amended and Restated Promissory Note, or the “Tenth Amendment”, with Berkshire Bank. The Tenth Amendment, among other things, extended the maturity date of the Revolver Loan from January 15, 2025 to April 30, 2025

Read about the Berkshire Bank Loans under the “Liquidity and Capital Resources” section below, for a discussion of the amended debt agreement and its impact on the Company’s liquidity and on-going operations.

Private Placement

On July 3, 2024, the Company entered into a Securities Purchase Agreement with certain accredited investors, pursuant to which the Company sold 521,800 shares of the Company’s common stock, par value $0.0001 per share, and 521,800 common stock purchase warrants to purchase 521,800 shares of Common Stock in a private placement at an aggregate purchase price of $1,801.The combined purchase price for one share and one warrant was $3.45. The purpose of the private placement was to raise working capital for use by the Company. The closing of the offering occurred on July 8, 2024. Placement agent’s fees in connection with the offering totaled $123. In addition, the Company issued to the placement agent common stock purchase warrants to purchase up to 19,983 shares of common stock

On February 11. 2025, the Company received $498 in proceeds from the sale of the remaining shares of the Company’s common stock, and common stock purchase warrants in a private placement pursuant to a Securities Purchase Agreement with certain accredited investors which closed on July 8, 2024.

Pursuant to the agreement, we agreed to have a registration statement registering for resale the shares and the shares underlying the warrants declared effective with 60 days of the closing date. The registration statement was declared effective by the Securities and Exchange Commission on January 31, 2025. Since the registration statement was not declared effective in a timely manner, and the Company is now obligated to pay approximately $108 as liquidated damages under the agreement which is included in accrued expenses on the balance sheet.

Critical Accounting Policies and Estimates

The preparation of the condensed consolidated financial statements requires that we make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures. We base our estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We continually evaluate our estimates, including those related to revenue recognition and income taxes. These estimates and assumptions require management’s most difficult, subjective or complex judgments. Actual results may vary under different assumptions or conditions.

We consider the principles and estimates applied for revenue recognition as one of our most critical accounting estimates. Our revenue can fluctuate from quarter-to-quarter as we measure revenue recognition over the duration of a project, or at the end of the project. The Company records most of its revenue over-time as it completes performance obligations or at a point-in-time, for example, at the delivery date, when control of the promised goods is transferred to the customer. Project volume for revenue recognized at a point-in-time is generally smaller, can fluctuate from period-to-period, and is difficult to forecast.

We measure progress for performance obligations satisfied over time using input methods such as labor hours expended. As a result, we review inputs and outputs and can estimate the remaining amounts of inputs needed to complete the work and therefore report an accurate amount of revenue each reporting period. The amount of revenue period-to-period will fluctuate based on project volume.

Our significant accounting policies are set forth in detail in Note 2 to the consolidated financial statements included in the 2024 Annual Report on Form 10-K. There were no significant changes to our critical accounting policies during the three months ended December 31, 2024.

25

Table of Contents

New Accounting Standards

See Note 2, Basis of Presentation and Significant Accounting Policies, in the Notes to the Unaudited Condensed Consolidated Financial Statements under “Item 1. Financial Statements”, for a discussion of recently adopted new accounting guidance.

Results of Operations

Our results of operations are affected by a number of external factors including the availability of raw materials, commodity prices (particularly steel), macroeconomic factors, including the availability of capital that may be needed by our customers, and political, regulatory and legal conditions in the United States and in foreign markets. It generally takes approximately twelve months or less to complete our manufacturing projects. However, contracts for larger complex components can take up to thirty-six months in general to complete. Units manufactured under the majority of our customer contracts have historically been delivered on time and with a positive gross margin. Our results of operations are also affected by our success in booking new contracts, the timing of revenue recognition, delays in customer acceptances of our products, delays in deliveries of ordered products and our rate of progress fulfilling obligations under our contracts. Delays in any of these items could have an unfavorable impact on liquidity, cause us to have inventories in excess of our short-term needs, and delay our ability to recognize, or prevent us from recognizing, revenue on contracts in our order backlog.

Gross profit and gross margin in the defense segments are driven by changes in volume, performance or contract mix. Performance refers to changes in profitability based on adjustments to estimates at completion on individual contracts. These adjustments can result from increases or decreases to the estimated value of the contract, the estimated costs to complete the contract or both.

We evaluate the performance of our segments based upon, among other things, segment revenue, operating profit, and certain key performance indicators. Segment operating profit excludes general corporate costs, which include executive and director compensation, stock-based compensation, certain retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments.

Key Performance Indicators

While we prepare our financial statements in accordance with U.S. generally accepted accounting principles, or “U.S. GAAP”, we also utilize and present certain financial measures that are not based on or included in U.S. GAAP. We refer to these as non-GAAP financial measures. Please see the section titled “EBITDA Non-GAAP financial measure” below for further discussion of these financial measures, including the reasons why we use such financial measures and reconciliations of such financial measures to the most directly comparable U.S. GAAP financial measures.

Percentages in the following tables and throughout this “Results of Operations” section may reflect rounding adjustments. All dollars are in thousands except per share data.

26

Table of Contents

Three Months Ended December 31, 2024 and 2023

The following table presents revenue, cost of revenue and gross profit, consolidated and by reportable segment:

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | December 31, 2024 | ​ | December 31, 2023 | ​ | Changes | ​
​ | ​ | ​ | ​ | Percent of | ​ | ​ | ​ | Percent of | ​ | ​ | ​ | ​ | ​
​ |  | Amount |  | Revenue |  | Amount |  | Revenue |  | Amount |  | Percent |
Revenue | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Ranor | ​ | $ | 4,310 | ​ | 57 | % | $ | 4,296 | ​ | 56 | % | $ | 14 | ​ | — | %
Stadco | ​ | ​ | 3,312 | ​ | 43 | % | ​ | 3,370 | ​ | 44 | % | ​ | (58) | ​ | (2) | %
Intersegment elimination | ​ | ​ | — | ​ | — | % | ​ | (16) | ​ | — | % | ​ | 16 | ​ | 100 | %
Consolidated Revenue | ​ | $ | 7,622 | ​ | 100 | % | $ | 7,650 | ​ | 100 | % | $ | (28) | ​ | — | %
Cost of revenue | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Ranor | ​ | $ | 2,798 | ​ | 37 | % | $ | 2,919 | ​ | 38 | % | $ | (121) | ​ | (4) | %
Stadco | ​ | ​ | 3,833 | ​ | 50 | % | ​ | 3,586 | ​ | 47 | % | ​ | 247 | ​ | 7 | %
Intersegment elimination | ​ | ​ | — | ​ | — | % | ​ | (16) | ​ | — | % | ​ | 16 | ​ | 100 | %
Consolidated Cost of revenue | ​ | $ | 6,631 | ​ | 87 | % | $ | 6,489 | ​ | 85 | % | $ | 142 | ​ | 2 | %
Gross profit (loss) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Ranor | ​ | $ | 1,512 | ​ | 20 | % | $ | 1,377 | ​ | 18 | % | $ | 135 | ​ | 10 | %
Stadco | ​ | ​ | (521) | ​ | (7) | % | ​ | (216) | ​ | (3) | % | ​ | (305) | ​ | (141) | %
Consolidated Gross profit | ​ | $ | 991 | ​ | 13 | % | $ | 1,161 | ​ | 15 | % | $ | (170) | ​ | (15) | %

​

Revenue

Consolidated – Revenue was $7,622 for the three months ended December 31, 2024, a decrease of $28 or less than 1% when compared to revenue of $7,650 for the three months ended December 31, 2023. Revenue decreased at Stadco by $58, but increased at Ranor by $14.

Ranor – Revenue was $4,310 for the three months ended December 31, 2024, an increase of $14, or a percentage change of less than 1%. Our customer project mix was different when compared to the three months ended December 31, 2023, with a favorable change in volume which resulted in slightly higher revenue.

Stadco – Revenue was $3,312 for the three months ended December 31, 2024, a decrease of $58 or 2%. Compared to the same period a year ago, work on a different project mix resulted in lower relative contract values which more than offset a favorable change in volume. The result was slightly lower revenue for the three months ended December 31, 2024.

Gross profit (loss)

Consolidated – Cost of revenue consists primarily of raw materials, parts, labor, overhead and subcontracting costs. Our cost of revenue for the three months ended December 31, 2024, was $6,631, or 2% higher when compared to the three months ended December 31, 2023. The increase in cost of revenue was primarily the result of higher production costs and under - absorbed overhead at Stadco. As a result, gross profit decreased by $170 when compared to the same period a year ago. Consolidated gross margin for the three months ended December 31, 2024 was 13% compared to 15% in the same period a year ago.

Ranor – The cost of revenue decreased by $121, due to better throughput and higher absorbed overhead added to our work - in - progress. As a result, gross profit increased by $135 or 10% when compared with the same period a year ago.

Stadco – The cost of revenue increased by $247 on higher production costs as factory overhead was under absorbed and work on projects executed during the quarter used more direct labor hours when compared to the same period a year ago. As a result, gross profit was negative and increased by $305 or 141% when compared to the same period a year ago.

27

Table of Contents

Selling, General and Administrative (SG&A) Expenses

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | December 31, 2024 |  | December 31, 2023 | ​ | Changes |
​ | ​ | ​ | ​ | ​ | Percent of | ​ | ​ | ​ | ​ | Percent of | ​ | ​ | ​ | ​ | ​ |
​ |  | Amount |  | Revenue |  | Amount |  | Revenue |  | Amount |  | Percent |
Ranor | ​ | $ | 463 | ​ | 6 | % | $ | 362 | ​ | 5 | % | $ | 101 | ​ | 28 | %
Stadco | ​ |  | 333 | ​ | 4 | % | ​ | 298 | ​ | 4 | % | ​ | 35 | ​ | 12 | %
Corporate and unallocated | ​ |  | 891 | ​ | 12 | % | ​ | 1,497 | ​ | 19 | % | ​ | (606) | ​ | (40) | %
Consolidated SG&A | ​ | $ | 1,687 | ​ | 22 | % | $ | 2,157 | ​ | 28 | % | $ | (470) | ​ | (22) | %

​

Consolidated – Total selling, general and administrative expenses decreased by $470, or 22%, primarily due to the absence of due diligence work on acquisitions. Corporate expenses were higher in the same period a year ago because of due diligence work in connection with the terminated Votaw acquisition.

Ranor – SG&A expense increased by $101 as an increase in compensation more than offset a decrease in office costs.

Stadco – SG&A expense increased by $35 due primarily to a slight increase in compensation when compared with the same period a year ago.

Corporate and unallocated – SG&A decreased by $606 or 40%, due primarily to the absence of due diligence work on acquisitions. Other corporate expenses increased by $100. Expenses of $700 were recorded for due diligence work in the same period a year ago in connection with the terminated Votaw acquisition.

Operating (loss) income

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | December 31, 2024 | ​ | December 31, 2023 | ​ | Changes |
​ | ​ | ​ | ​ | Percent of | ​ | ​ | ​ | Percent of | ​ | ​ | ​ | ​ |
​ |  | Amount |  | Revenue |  | Amount |  | Revenue |  | Amount |  | Percent |
Ranor | ​ | $ | 1,049 | ​ | 14 | % | $ | 1,015 | ​ | 13 | % | $ | 34 | ​ | 3 | %
Stadco | ​ |  | (854) | ​ | (11) | % | ​ | (514) | ​ | (7) | % | ​ | (340) | ​ | (66) | %
Corporate and unallocated | ​ |  | (891) | ​ | (12) | % | ​ | (1,497) | ​ | (19) | % | ​ | 606 | ​ | 40 | %
Operating loss | ​ | $ | (696) | ​ | (9) | % | $ | (996) | ​ | (13) | % | $ | 300 | ​ | 30 | %

​

Consolidated – For the three months ended December 31, 2024, we recorded an operating loss of $696 compared with the operating loss of $996 for the three months ended December 31, 2023. The change was primarily due to lower corporate expenses because of the absence of due diligence work for acquisitions, which more than offset an operating loss at Stadco. Corporate expenses were higher in the same period a year ago for due diligence work in connection with the terminated Votaw acquisition.

Ranor – Operating income increased by $34 or 3% due to a favorable period of operating execution and throughput.

Stadco – Operating loss increased by $340 or 66% as certain production issues continue to impact throughput.

Corporate and unallocated – Expenses decreased by $606 or 40%, primarily on the absence of due diligence work for acquisitions. We recorded $700 in the same period of the prior year in connection with due diligence for the terminated Votaw acquisition.

Other Income (Expense), net

The following table presents other income (expense) for the three months ended:

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | December 31, 2024 |  | December 31, 2023 |  | $ Change |  | % Change |
Other income | ​ | $ | 44 | ​ | $ | — | ​ | $ | 44 | ​ | nm | %
Interest expense | ​ | $ | (118) | ​ | $ | (92) | ​ | $ | (26) | ​ | (28) | %
Amortization of debt issue costs | ​ | $ | (29) | ​ | $ | (18) | ​ | $ | (11) | ​ | (61) | %

nm - not meaningful

28

Table of Contents

Interest expense increased by $26 when compared with the three months ended December 31, 2023, due primarily to an increase in borrowings under the revolver loan.

Amortization of debt issue costs for the three months ended December 31, 2024 increase by $11 when compared to three months ended December 31, 2023, on higher debt issue costs incurred for extending the revolver loan maturity dates.

Other income, net for the three months ended December 31, 2024 includes a payment for non - operating filming activities.

Income Tax expense (benefit)

Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences and carryforwards are expected to be recovered or settled. We believe that it is more likely than not that the benefit from certain state NOL carryforwards and other deferred tax assets will not be realized. The assessment was based on the weight of negative evidence at the balance sheet date, our recent operating losses and unsettled circumstances that, if unfavorably resolved, would adversely affect future operations and profit levels. In recognition of this risk, we continue to provide a valuation allowance on these items.

For the three months ended December 31, 2024, there has been no change in our judgment about the realizability of deferred tax assets in future years, and, therefore, no expense or benefit provided for income taxes. For the three months ended December 31, 2023, the Company recorded a tax benefit of $241.

Net Loss

As a result of the foregoing, for the three months ended December 31, 2024, we recorded a net loss of $799, or $0.08 per share basic and fully diluted, compared with a net loss of $865, or $0.10 per share basic and fully diluted for the three months ended December 31, 2023.

Nine Months Ended December 31, 2024 and 2023

The following table presents revenue, cost of revenue and gross profit, consolidated and by reportable segment:

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | December 31, 2024 |  | December 31, 2023 |  | Changes |
​ | ​ | ​ | ​ | Percent of | ​ | ​ | ​ | Percent of | ​ | ​ | ​ | ​ |
​ |  | Amount |  | Revenue |  | Amount |  | Revenue |  | Amount |  | Percent |
Revenue |  | ​ |  |  |  |  | ​ |  |  |  |  | ​ |  |  |  | ​
Ranor | ​ | $ | 13,482 |  | 55 | % | $ | 13,291 |  | 58 | % | $ | 191 |  | 1 | %
Stadco | ​ |  | 11,139 |  | 45 | % |  | 9,943 |  | 43 | % |  | 1,196 |  | 12 | %
Intersegment elimination | ​ |  | (67) |  | --- | % |  | (243) |  | (1) | % |  | 176 |  | 72 | %
Consolidated Revenue | ​ | $ | 24,554 |  | 100 | % | $ | 22,991 |  | 100 | % | $ | 1,562 |  | 7 | %
Cost of revenue | ​ |  | ​ |  | ​ | ​ |  | ​ |  | ​ | ​ |  | ​ |  | ​ | ​
Ranor | ​ | $ | 9,215 |  | 38 | % | $ | 9,382 |  | 40 | % | $ | (167) |  | (2) | %
Stadco | ​ |  | 13,161 |  | 54 | % |  | 10,962 |  | 48 | % |  | 2,199 |  | 20 | %
Intersegment elimination | ​ |  | (67) |  | — | % |  | (243) |  | (1) | % |  | 176 |  | 72 | %
Consolidated Cost of revenue | ​ | $ | 22,309 |  | 92 | % | $ | 20,101 |  | 87 | % | $ | 2,208 |  | 11 | %
Gross profit (loss) | ​ |  | ​ |  | ​ | ​ |  | ​ |  | ​ | ​ |  | ​ |  | ​ | ​
Ranor | ​ | $ | 4,266 |  | 17 | % | $ | 3,703 |  | 16 | % | $ | 563 |  | 15 | %
Stadco | ​ |  | (2,022) |  | (8) | % |  | (813) |  | (3) | % |  | (1,209) |  | (149) | %
Consolidated Gross profit | ​ | $ | 2,244 |  | 9 | % | $ | 2,890 |  | 13 | % | $ | (646) |  | (22) | %

​

Revenue

Consolidated - Revenue was $24,553 for the nine months ended December 31, 2024, or 7% higher when compared to revenue of $22,991 for the nine months ended December 31, 2023. Revenue increased by $1,196 at Stadco and $191 at Ranor. A different project mix delivered a favorable change on relative contract values year-over-year. However, as described in the gross profit and gross margin section below, higher or lower relative contracts prices may not necessarily result in higher or lower gross profit or gross margin. Consolidated backlog was $45,522 as of December 31, 2024. Our project order flow from prime defense contactors remains strong.

29

Table of Contents

Ranor – Revenue was $13,481 for the nine months ended December 31, 2024, an increase of $191 or 1% higher when compared to the same period a year ago. For the nine months ended December 31, 2024 we executed on a different project mix with a favorable change to relative contract values when compared to the same period a year ago.

The backlog at Ranor remains strong as new orders continue to flow to us from our existing customer base of prime defense contractors. The backlog at Ranor on December 31, 2024 and 2023 was $20,344 and $18,497, respectively.

Stadco – Revenue was $11,139 for the nine months ended December 31, 2024, compared with revenue of $9,943 for the nine months ended December 31, 2023, an increase of $1,196, or 12%. We executed on a different project mix with favorable changes to volume and relative contract values when compared with the nine months ended December 31, 2023.

The backlog remains strong as new orders for components related to a variety of programs, including the U.S. Marine Corps heavy lift helicopter programs, continue to flow to us from our existing customer base of prime defense contractors. Stadco’s backlog was $25,178 and $32,424 as of December 31, 2024 and 2023, respectively.

Gross profit (loss)

Consolidated – Cost of revenue consists primarily of raw materials, parts, labor, overhead and subcontracting costs. Our cost of revenue for the nine months ended December 31, 2024, was $22,309, or 11% higher when compared to the nine months ended December 31, 2023. The increase in cost of revenue was primarily the result of higher production costs and under - absorbed overhead at Stadco. As a result, gross profit decreased by $646, or 22% when compared to the same period a year ago. Gross margin for the nine months ended December 31, 2024 was 9% compared to 13% in the same period a year ago.

Ranor – Cost of revenue decreased by $167 or 2% when compared with the same period a year ago. Higher absorbed overhead was added to our work - in - progress which more than offset an increase in material costs. As a result, gross profit increased by $563 or 15% when compared with the same period a year ago.

Stadco – Cost of revenue increased by $2,199 or 20%. Factory overhead was under absorbed, and other production costs, repairs and maintenance, and certain project losses increased year-over-year. Gross profit was negative $2,022 or a 149% increase for the nine months ended December 31, 2024, as our losses widened when compared to the same period a year ago.

Selling, General and Administrative (SG&A) Expenses

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | December 31, 2024 |  | December 31, 2023 |  | Changes |
​ |  | ​ |  | Percent of |  | ​ |  | Percent of | ​ | ​ |  | ​ |
​ | ​ | Amount | ​ | Revenue | ​ | Amount | ​ | Revenue | ​ | Amount | ​ | Percent |
Ranor | ​ | $ | 1,164 |  | 5 | % | $ | 1,141 |  | 5 | % | $ | 23 |  | 2 | %
Stadco | ​ |  | 990 |  | 4 | % |  | 928 |  | 4 | % |  | 62 |  | 7 | %
Corporate and unallocated | ​ |  | 2,615 |  | 10 | % |  | 2,994 |  | 13 | % |  | (379) |  | (13) | %
Consolidated SG&A | ​ | $ | 4,769 |  | 19 | % | $ | 5,063 |  | 22 | % | $ | (295) |  | (6) | %

​

Consolidated – Total selling, general and administrative expenses decreased by $295, or 6%, primarily due to the absence of due diligence work on acquisitions. We also accrued $419 in connection with a breakup fee for the terminated Votaw acquisition in the first quarter of fiscal 2025. Other corporate expenses increased by $202 during the nine months ended December 31, 2024. We incurred corporate expenses of $1,000 for due diligence work during the nine months ended December 31, 2023 in connection with the terminated Votaw acquisition.
​

Ranor – SG&A expense increased by $22 or 2% due primarily to an increase in compensation which slightly offset a decrease in travel expense.

Stadco – SG&A expense increased by $62 or 7%, due primarily to an increase for outside advisory and office costs.

Corporate and unallocated – SG&A decreased by $379 primarily due to the absence of due diligence work on acquisitions. We also accrued $419 in connection with a breakup fee for the terminated Votaw acquisition in the first quarter of fiscal 2025. Other corporate expenses increased by $202 during the nine months ended December 31, 2024. We incurred corporate expenses of $1,000 for due diligence work were recorded during the nine months ended December 31, 2023 in connection with the terminated Votaw acquisition.

30

Table of Contents

Operating (loss) income

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | December 31, 2024 | ​ | December 31, 2023 | ​ | Changes |
​ | ​ | ​ | ​ | Percent of | ​ | ​ | ​ | Percent of | ​ | ​ | ​ | ​ |
​ |  | Amount |  | Revenue |  | Amount |  | Revenue |  | Amount |  | Percent |
Ranor | ​ | $ | 3,103 |  | 13 | % | $ | 2,562 |  | 11 | % | $ | 541 |  | 21 | %
Stadco | ​ |  | (3,013) |  | (12) | % |  | (1,741) |  | (8) | % |  | (1,272) |  | (73) | %
Corporate and unallocated | ​ |  | (2,615) |  | (11) | % |  | (2,994) |  | (13) | % |  | 379 |  | 13 | %
Operating loss | ​ | $ | (2,525) |  | 10 | % | $ | (2,173) |  | (10) | % | $ | (351) |  | (16) | %

​

Consolidated – For the nine months ended December 31, 2024, we reported an operating loss of $2,525, or 16% higher when compared with the operating loss for the nine months ended December 31, 2023. The change was primarily due to operating losses at Stadco which more than offset income at Ranor, and lower corporate expenses.

Ranor – Operating income increased by $541 or 21% when compared to the same period a year ago, due primarily to a favorable nine-month period of execution and efficient throughput.

Stadco – Operating loss increased by $1,272 or 73% as certain production issues disrupted throughput for the nine months ended December 31, 2024.

Corporate and unallocated – Operating loss decreased by $379 or 13%, due primarily to the absence of due diligence work on acquisitions. We accrued $419 in connection with a breakup fee for the terminated Votaw acquisition in the first quarter of fiscal 2025, and other corporate expenses increased by $202 during the nine months ended December 31, 2024. We incurred corporate expenses of $1,000 during the nine months ended December 31, 2023 in connection with the terminated Votaw acquisition.

Other Income (Expense), net

The following table presents other income (expense) for the nine months ended:

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | December 31, 2024 |  | December 31, 2023 |  | $Change |  | % Change |
Other income | ​ | $ | 57 | ​ | $ | 41 | ​ | $ | 16 |  | 39 | %
Interest expense | ​ | $ | (325) | ​ | $ | (297) | ​ | $ | (28) |  | (9) | %
Amortization of debt issue costs | ​ | $ | (67) | ​ | $ | (55) | ​ | $ | (12) |  | (22) | %

​

Interest expense increased by $28 when compared with the nine months ended December 31, 2023, due primarily to an increase in borrowings under the revolver loan.

Amortization of debt issue costs for the nine months ended December 31, 2024, was higher when compared to three months ended December 31, 2023 due to an increase in issue costs for extending the revolver loan maturity dates.

Other income, net, in the table above, for the nine months ended December 31, 2024, includes a payment for non - operating filming activities and a vendor rebate for $11. Other income, net for the three months ended December 31, 2023 includes a gain from the disposal of fixed assets.

Income Tax expense (benefit)

Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences and carryforwards are expected to be recovered or settled. We believe that it is more likely than not that the benefit from certain state NOL carryforwards and other deferred tax assets will not be realized. The assessment was based on the weight of negative evidence at the balance sheet date, our recent operating losses and unsettled circumstances that, if unfavorably resolved, would adversely affect future operations and profit levels. In recognition of this risk, we continue to provide a valuation allowance on these items.

For the nine months ended December 31, 2024, there has been no change in our judgment about the realizability of deferred tax assets in future years, and, therefore, no expense or benefit provided for income taxes. For the nine months ended December 30, 2023, the Company recorded a tax benefit $563.

31

Table of Contents

Net Loss

As a result of the foregoing, for the nine months ended December 31, 2024, we recorded a net loss of $2,860, or $0.30 per share basic and fully diluted, compared with a net loss of $1,921, or $0.22 per share basic and fully diluted for the nine months ended December 31, 2023.

Liquidity, Capital Resources and Going Concern

Our liquidity is highly dependent on the availability of financing facilities and our ability to generate positive operating cash flow.

As of December 31, 2024, we had approximately $330 in total available liquidity, consisting primarily of approximately $165 in undrawn capacity under our Revolver Loan and $165 of available cash. As of March 31, 2024, we had $677 in total available liquidity, consisting of $138 in cash and cash equivalents, and approximately $539 in undrawn capacity under our Revolver Loan.

There was $2,930 and $2,800 outstanding under the Revolver Loan on December 31, 2024 and March 31, 2024, respectively. The Company pays interest at an adjusted SOFR - based rate. Interest - only payments on advances made under the Revolver Loan will continue to be payable monthly in arrears. Interest paid and accrued on advances made under the Revolver Loan during the nine months ended December 31, 2024, and 2023 totaled $146 and $117, respectively. The weighted average interest rate on December 31, 2024 and March 31, 2024 was 7.65% and 7.60%, respectively. The weighted average amount outstanding during the period ending December 31, 2024 was $2,534. Unused borrowing capacity as of December 31, 2024 and March 31, 2024 was approximately $165 and $539, respectively.

At December 31, 2024 and March 31, 2024 our working capital was negative in part because of the reclassification of our long - term debt from noncurrent to current in the condensed consolidated balance sheet. The table below presents selected liquidity and capital measures as of:

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | December 31, |  | March 31, |  | Change
​ | ​ | 2024 | ​ | 2024 | ​ | Amount
Cash and cash equivalents | ​ | $ | 165 | ​ | $ | 138 | ​ | $ | 27
Revolver loan – available borrowing capacity | ​ | $ | 165 | ​ | $ | 539 | ​ | $ | (374)
Working capital | ​ | $ | (1,756) | ​ | $ | (2,904) | ​ | $ | 1,148
Total debt | ​ | $ | 7,377 | ​ | $ | 7,648 | ​ | $ | (271)
Total stockholders’ equity | ​ | $ | 8,101 | ​ | $ | 7,803 | ​ | $ | 298

​

The next table summarizes changes in cash by primary component in the cash flows statements for the nine months ended:

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | December 31, |  | December 31, |  | Change
​ | ​ | 2024 | ​ | 2023 | ​ | Amount
Operating activities | ​ | $ | (995) | ​ | $ | 1,180 | ​ | $ | (2,175)
Investing activities | ​ |  | (230) | ​ | ​ | (2,720) | ​ | ​ | 2,490
Financing activities | ​ |  | 1,252 | ​ | ​ | 1,397 | ​ | ​ | (145)
Net increase (decrease) in cash | ​ | $ | 27 | ​ | $ | (143) | ​ | $ | 170

​

Operating activities

Apart from our loan facilities, our primary sources of cash are from customer revenue, customer contract advances, and associated accounts receivable collections. Many of our customers make advance payments and progress payments under the terms of each manufacturing contract. The composition of our accounts receivable collections mix changes between advance payments and customer payments made after shipment of finished goods. Our cash flows can fluctuate from period to period as we mark progress with customer project milestones and the timing of progress payments.

Cash used in operating activities for the nine months ended December 31, 2024, was $995. Our net loss adjusted by our non - cash adjustments used $54 of cash during the nine months ended December 31, 2024, as compared to cash used of $360 to the same period a year ago. Working capital changes to our balance sheet used $941 of cash during the nine months ended December 31, 2024, as compared to $1,539 of cash provided in the same period a year ago.

32

Table of Contents

Investing activities

For the nine months ended December 31, 2024, we invested $2,796 in new factory machinery and equipment and were reimbursed for $2,566 of certain purchases under a supplier development fund.

We are subject to certain financial debt covenants and may not spend more than $1,500 for new machinery and equipment during any single fiscal year, excluding supplier development funding, tested on an annual basis at the end of each fiscal year. We estimate that our spending on new machinery and equipment in fiscal 2025 will not exceed that spending limitation.

For the nine months ended December 31, 2023, we invested $2,782 in new factory machinery and equipment.

Financing activities

We drew down $10,526 of proceeds under our Revolver Loan during the nine months ended December 31, 2024, and repaid $10,381 during the same period. We also used $488 of cash to pay down debt principal and make periodic lease payments.

On July 3, 2024, the Company sold 521,800 shares of the Company’s common stock, par value $0.0001 per share, and 521,800 common stock purchase warrants to purchase 521,800 shares of Common Stock in a private placement at an aggregate purchase price of $1,801. Placement agent’s fees in connection with the offering totaled $213.

For the nine months ended December 31, 2023 we drew down $10,160 of proceeds under the Revolver Loan and repaid $8,260 during the same period. We also used approximately $463 of cash to pay down debt principal and make periodic lease payments.

All of the above activity resulted in a net increase in cash of $27 for the nine months ended December 31, 2024 compared with a net decrease in cash of $143 for the nine months ended December 31, 2023.

Berkshire Bank Loans

On August 25, 2021, the Company entered into an amended and restated loan agreement with Berkshire Bank (as amended to date, the “Loan Agreement”). Under the Loan Agreement, Berkshire Bank will continue to provide the Ranor Term Loan (as defined below) and the revolving line of credit, or the “Revolver Loan”. In addition, Berkshire Bank provided the Stadco Term Loan (as defined below) in the original amount of $4,000. The proceeds of the original Ranor Term Loan of $2,850 were previously used to refinance existing mortgage debt of Ranor. The proceeds of the Revolver Loan are used for working capital and general corporate purposes of the Company. Payments for the original Ranor Term Loan began on January 20, 2017, and until the facility was amended in December 2022, the Company paid monthly installments of $19 each, inclusive of interest at a fixed rate of 5.21% per annum.

The proceeds of the Stadco Term Loan were used to support the acquisition of Stadco and refinance existing indebtedness of Stadco. Interest on the Stadco Term Loan is due on unpaid balances beginning on August 25, 2021, at a fixed rate per annum equal to the 7-year Federal Home Loan Bank of Boston Classic Advance Rate plus 2.25%. Since September 25, 2021, and on the 25th day of each month thereafter, Stadco has made and will continue to make monthly payments of principal and interest in the amount of $54 each, with all outstanding principal and accrued interest due and payable on August 25, 2028.

On June 12, 2023, the Company and Berkshire Bank executed a waiver under which Berkshire Bank waived the Company’s noncompliance with the capital expenditure limit on March 31, 2023. The waiver document also contains an agreement by the parties to exclude from the calculation of capital expenditures for purposes of the Loan Agreement during the year ending March 31, 2024, any such expenditures made by the Company to the extent they are made using funds provided by customers of the Company for the purpose of making such capital expenditures.

On December 20, 2023, Ranor and certain affiliates of the Company entered into a Sixth Amendment to Amended and Restated Loan Agreement and Second Amendment to Second Amended and Restated Promissory Note, or the “Sixth Amendment”. The Sixth Amendment, among other things (i) extended the maturity date of the Revolver Loan from December 20, 2023 to March 20, 2024; (ii) limited the use of proceeds from the Revolver Loan by the Company or its affiliates to $1,000 in the aggregate for due diligence and related professional costs incurred on or prior to March 20, 2024 in connection with any acquisitions; and (iii) makes certain changes to the amount and methods of valuation of equipment securing repayment of the borrowed funds.

33

Table of Contents

On March 20, 2024, Ranor and certain affiliates of the Company entered into a Seventh Amendment to Amended and Restated Loan Agreement and Third Amendment to Second Amended and Restated Promissory Note, or the “Seventh Amendment”. Effective March 20, 2024, the Seventh Amendment, among other things (i) extended the maturity date of the Revolver Loan from March 20, 2024 to May 20, 2024, and (ii) limited the use of proceeds from the Revolver Loan by the Company or its affiliates to $2,000 in the aggregate for due diligence and related professional costs incurred on or prior to May 10, 2024 in connection with any acquisitions.

On May 28, 2024, Ranor and the other Borrowers entered into an Eighth Amendment to Amended and Restated Loan Agreement and Fourth Amendment to Second Amended and Restated Promissory Note with Berkshire Bank. Effective May 24, 2024, the Eighth Amendment, among other things, (i) extended the maturity date of the Revolver Loan from May 24, 2024 to August 30, 2024; (ii) amended the maximum principal amount of the Revolver Loan from $5,000 to $4,500; and (iii) effective on June 1, 2024, increases the Term SOFR Margin (as defined in the Amendment) used to calculate the interest rate from 2.25% per annum to 2.50% per annum.

On September 4, 2024, Ranor and the other Borrowers entered into a Ninth Amendment to Amended and Restated Loan Agreement and Fifth Amendment to Second Amended and Restated Promissory Note, or the “Ninth Amendment”, with Berkshire Bank. Effective August 30, 2024, the Ninth Amendment, among other things, extended the maturity date of the Revolver Loan from August 30, 2024 to January 15, 2025.

On December 19, 2024, Ranor and the other Borrowers entered into a Tenth Amendment to Amended and Restated Loan Agreement and Sixth Amendment to Second Amended and Restated Promissory Note, or the “Tenth Amendment”, with Berkshire Bank. the Tenth Amendment, among other things, extended the maturity date of the Revolver Loan from January 15, 2025 to April 30, 2025.

As a result of Borrowers’ failure to satisfy the required minimum Debt Service Coverage Ratio for the twelve (12) month periods ending March 31, 2024 and December 31, 2024, as set forth in the Loan Agreement, or the “Existing Default”, the borrowers acknowledge that a certain Event of Default has occurred and is continuing under the Loan Agreement. The borrowers further acknowledge that the sixth amendment to the Agreement constitutes written notice pursuant to the Loan Documents of such Existing Default. Regardless of entering into this Agreement or any discussions between Borrowers and Lender, the Lender expressly reserves any and all rights and remedies available to it under the Loan Documents, the Collateral Documents, and under applicable law, including, without limitation, its right to choose to accelerate and demand the outstanding indebtedness evidenced by the Loan Documents and seek immediate repayment in full, and institute the default rate of interest as of the date of the occurrence of the default or at any time thereafter, as a result of any default or event of default, including, without limitation, the Existing Default, that have arisen or may arise. No such discussions or the entering into of this Agreement shall imply any course of conduct or any agreement on the part of Lender to waive any of its rights and remedies or to forbear from taking any action authorized by the Loan Documents, the Collateral Documents, or by applicable law while discussions continue.

There was $7,327 and $7,648 outstanding under the Loan Agreement on December 31, 2024 and March 31, 2024, respectively. Without a waiver, the lender has the right, but not the obligation, to demand repayment from the Company for noncompliance with the debt covenants. In addition, the bank retains the right to act on covenant violations that occur after the date of delivery of any waiver. The lender has not granted us a waiver. As such, we need to seek alternative financing to pay these obligations as the Company does not have existing facilities or sufficient cash on hand to satisfy these obligations. It is also probable that the Company will not be in compliance with the same debt covenants at subsequent measurement dates within the next twelve months. As a result of the above, all of our long-term debt has been classified as current in our condensed consolidated balance sheet.

The Company is exploring various means of strengthening its liquidity position and ensuring compliance with its debt financing covenants by making Stadco operations profitable, renewing our revolver loan, or entering into alternative debt facilities.

On July 3, 2024, the Company entered into a Security Purchase Agreement with certain accredited investors, pursuant to which the Company sold common stock and warrants in a private placement at an aggregate purchase price of approximately $1,801. The combined purchase price for one share of common stock and one warrant was $3.45. The purpose of the sale of the common stock and warrants was to raise working capital for use by the Company. The closing of the offering occurred on July 8, 2024.

In order for us to continue operations beyond the next twelve months from the date of issuance of the financial statements and to be able to discharge our liabilities and commitments in the normal course of business, we must renew our revolver loan or seek alternative financing by April 30, 2025. We must mitigate our recurring operating losses at our Stadco subsidiary, efficiently increase utilization of our manufacturing capacity at Stadco and improve the manufacturing process. We plan to closely monitor our expenses and, if required, will reduce operating costs to enhance liquidity.

34

Table of Contents

The uncertainty associated with the recurring operating losses at Stadco, the revolver loan renewal, the need for alternative financing, and compliance with debt covenants at subsequent measurement dates raise substantial doubt about our ability to continue as a going concern for at least one-year after the date the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q are issued.

Collateral securing all the above obligations comprises all personal and real property of the Company, including cash, accounts receivable, inventories, equipment, and financial assets.

Commitments and Contractual Obligations

The following contractual obligations associated with our normal business activities are expected to result in cash payments in future periods, and include the following material items as of December 31, 2024:

| ● | Our debt obligations, including fixed and variable-rate debt, totaled $7,327, and, because of current debt covenant violations, are classified as current in the consolidated balance sheets.

| ● | We enter into various commitments with suppliers for the purchase of raw materials and work supplies. Our outstanding unconditional contractual commitments, including for the purchase of raw materials and supplies goods, totaled approximately $7,349, all of it due to be paid within the next twelve months. These purchase commitments are in the normal course of business.

| ● | Our operating lease obligations, including imputed interest, totaled $4,583 for buildings through 2030, with approximately $940 due annually for each of the next five years and $391 in year six.

There are no off-balance sheet arrangements as of December 31, 2024.

EBITDA Non-GAAP Financial Measure

To complement our condensed consolidated statements of operations and condensed consolidated statements of cash flows, we use EBITDA, a non-GAAP financial measure. Net loss is the financial measure calculated and presented in accordance with U.S. GAAP that is most directly comparable to EBITDA. We believe EBITDA provides our board of directors, management, and investors with a helpful measure for comparing our operating performance with the performance of other companies that have different financing and capital structures or tax rates. We also believe that EBITDA is a measure frequently used by securities analysts, investors, and other interested parties in the evaluation of companies in our industry, and is a measure contained in our debt covenants. However, while we consider EBITDA to be an important measure of operating performance, EBITDA and other non-GAAP financial measures have limitations, and investors should not consider them in isolation or as a substitute for analysis of our results as reported under U.S. GAAP.

We define EBITDA as net loss plus interest, income taxes, depreciation, and amortization. Net loss was $799 and $865 for the three months ended December 31, 2024 and 2023, and $2,860 and $1,921 for the nine months ended December 31, 2024 and 2023. EBITDA, a non - GAAP financial measure, was negative for the nine months ended December 31, 2024 and 2023. The following table provides a reconciliation of EBITDA to net income (loss), the most directly comparable U.S. GAAP measure reported in our condensed consolidated financial statements for the three and nine months ended:

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months ended December 31, | ​ | Nine Months ended December 31,
​ |  | 2024 |  | 2023 |  | Change |  | 2024 |  | 2023 |  | Change
Net loss | ​ | $ | (799) | ​ | $ | (865) | ​ | $ | 66 | ​ | $ | (2,860) | ​ | $ | (1,921) | ​ | $ | (939)
Income tax benefit | ​ | ​ | — | ​ | ​ | (240) | ​ | ​ | 240 | ​ | ​ | — | ​ | ​ | (563) | ​ | ​ | 563
Interest expense (1) | ​ | ​ | 147 | ​ | ​ | 110 | ​ | ​ | 37 | ​ | ​ | 392 | ​ | ​ | 353 | ​ | ​ | 39
Depreciation and amortization | ​ | ​ | 703 | ​ | ​ | 631 | ​ | ​ | 72 | ​ | ​ | 2,093 | ​ | ​ | 1,759 | ​ | ​ | 334
EBITDA | ​ | $ | 51 | ​ | $ | (364) | ​ | $ | 415 | ​ | $ | (375) | ​ | $ | (372) | ​ | $ | (3)

(1) | Includes amortization of debt issue costs.

​

35

Table of Contents

Item 3. Quantitative and Qualitative Disclosure About Market Risk.

As a smaller reporting company, we have elected not to provide the information required by this Item.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures.

Disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) are controls and procedures that are designed to ensure that the information required to be disclosed in our reports filed or submitted under the Exchange Act, is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and includes controls and procedures designed to ensure that such information is accumulated and communicated to our management, including our Chief Executive Officer and Controller, as appropriate to allow timely decisions regarding required disclosure.

As of the end of the period covered by this report, an evaluation was carried out, under the supervision and with the participation of management, including our Chief Executive Officer and Controller, of the effectiveness of our disclosure controls and procedures. Based on that evaluation, our Chief Executive Officer and Controller concluded that, as of December 31, 2024, our disclosure controls and procedures were not effective due to the material weaknesses in our internal control over financial reporting described below.

Management’s Responsibility for Internal Controls

The Company’s internal control over financial reporting is designed under the supervision of our Chief Executive Officer and Chief Financial Officer, and effected by our board of directors, management, and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles, or U.S. GAAP. The Company’s internal control over financial reporting includes those policies and procedures that: (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the Company’s assets; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. GAAP, and that the Company’s receipts and expenditures are being made only in accordance with authorizations of the Company’s management and directors; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.

Inherent Limitations Over Internal Controls

Management, including the Chief Executive Officer and Chief Financial Officer, does not expect that the Company’s internal controls will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of internal controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. Also, any evaluation of the effectiveness of controls in future periods is subject to the risk that those internal controls may become inadequate because of changes in business conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Material Weaknesses

We identified three material weaknesses in our internal control over financial reporting as of March 31, 2024, which continues to exist at December 31, 2024. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis. In connection with the preparation of our financial statements for the Annual Report on Form 10-K, management identified the following material weaknesses:

(1) Purchase accounting – we did not maintain proper controls, processes and procedures over the initial purchase accounting and the fair value accounting associated with our acquisition of Stadco in the fiscal year ended March 31, 2022 that were adequately designed, documented, and executed to support the accurate and timely reporting of our financial results regarding the initial purchase accounting and the fair value accounting associated with the Stadco acquisition;

(2) Tax accounting – during fiscal 2023 and fiscal 2024 we did not maintain a sufficient complement of tax accounting personnel necessary to perform management review controls related to activities for extracting information to determine the

36

Table of Contents

valuation allowance at Stadco on a timely basis. These conditions led to certain omissions in the assessment of the valuation allowance during the third and fourth quarter of fiscal 2024. Because of this material weakness in fiscal 2023, we made a late or post-closing adjustment to our valuation allowance while preparing the consolidated financial statements and footnotes included in our Annual Report on Form 10-K for the period ended March 31, 2024;

(3) Stadco accounting – we did not maintain a sufficient complement of resources and expertise on the Stadco accounting staff necessary to consistently perform management review controls over financial information and complete account reconciliations on a timely basis, to ensure all transactions are accurately captured and recorded prior to closing the books. The demand on our accounting resources is significant due to the manual nature of controls necessary to maintain effective control over Stadco’s legacy system. As a result of this material weakness, we made several post-closing adjustments for percentage-of-completion (POC) revenue projects. The adjustment corrected inputs for project revenue and costs in progress at Stadco, as the initial and correcting journal entries were not reconciled and posted in a timely manner during the year end reporting cycle. Because of the foregoing reasons, extra time was required to complete certain items with respect to the financial statement preparation, closing and review process for the year ended March 31, 2024.

Notwithstanding the material weaknesses, management believes the consolidated financial statements included in this Quarterly Report on Form 10-Q present fairly, in all material respects, the Company’s financial condition, results of operations and cash flows as of and for the periods presented in accordance with U.S. GAAP.

Remediation of the Material Weaknesses

For the fiscal year ended March 31, 2024, we reviewed our entity level controls, staffing requirements and the cost/benefit for remediating our material weaknesses.

In fiscal 2024, our management, with the oversight of our audit committee, executed a plan to take measures to begin remediating the underlying causes of the material weaknesses through the development and implementation of a thorough review of our procedures, policies, processes, and review controls to gain additional assurance regarding the remediation our tax accounting, acquisition accounting procedures, and accounting closing cycle time at Stadco: (1) Purchase accounting - The Company enhanced its working framework with a memorandum that depicts a clear, explicit roadmap for the purchase accounting guidance at every step. We will follow that roadmap and if necessary, implement new controls. We engaged a third-party specialist in July 2023 with the requisite knowledge to perform all required valuations and accounting for business combinations. That specialist worked with the Company on all the pre-acquisition activities, or due diligence, in connection with the Votaw acquisition. The third-party specialist was hired primarily to assure that certain accounting issues that arose in the Stadco acquisition would not re-occur with the purchase accounting for the acquisition of Votaw; (2) Tax accounting - Management’s plan required that it utilize a tax specialist with the requisite knowledge and resources to perform the required basic and detailed tax calculations so that all the parties can make a timely assessment of the Company’s tax provision. The Company engaged a new tax specialist in July 2023, and that tax specialist now prepares our interim and annual tax provisions. We will implement new controls in fiscal 2025 to ensure a timely quarterly review of our deferred tax assets and liabilities and valuation allowance requirements as we facilitate remediation of the material weakness; (3) Stadco accounting - For the fiscal year ended March 31, 2024, we reviewed our entity level controls, staffing requirements and the cost/benefit for upgrading our legacy systems and accounting staff at Stadco. As a result of this review, we are transitioning accounting function to the office of the Chief Financial Officer in Massachusetts, where expert and experienced personnel are in-place to execute a plan to 1) improve the effectiveness and efficiency of the accounting operation, ensuring a timely closing cycle, 2) improve the reliability of financial reporting, and 3) continued compliance with generally accepted accounting principles and applicable laws and regulations. We began to implement these measures during fiscal 2024 and 2025 and we will monitor progress during fiscal 2026 as we facilitate remediation of the material weakness.

Management believes that the above actions continue the process of remediation for the material weakness as disclosed in our Annual Report on Form 10-K for the fiscal year ended March 31, 2024. The material weaknesses will not be considered remediated, however, until the applicable controls operate for a sufficient period and management has concluded, through testing, that these controls are operating effectively. We can provide no assurance as to when the remediation of these material weaknesses will be completed to provide for an effective control environment.

We are committed to continually improving our internal control process and will diligently review our financial reporting controls and procedures. As we continue to evaluate and work to improve our internal control over financial reporting, we may decide that additional measures are necessary to address control deficiencies.

37

Table of Contents

Changes in Internal Control over Financial Reporting

Except as disclosed under “Management’s Remediation Plan”, for the quarter ended December 31, 2024, there have been no changes in our internal control over financial reporting that have materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

Item 5. Other Information

During the three months ended December 31, 2024, none of our directors or officers informed us of the adoption or termination of a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

​

38

Table of Contents

PART II. Other Information.

Item 1. Legal Proceedings.

We may from time to time be subject to various legal or administrative claims and proceedings arising in the ordinary course of business. As of the date hereof, we are not a party to any material legal or administrative proceedings. Litigation or any other legal or administrative proceeding, regardless of the outcome, is likely to result in substantial cost and diversion of our resources, including our management’s time and attention.

On October 30, 2023, the Company and one of its employees were named as defendants in an action alleging individual claims of discrimination and wage and hour violations, along with representative wage and hour claims brought pursuant to the California Private Attorneys General Act of 2004 (“PAGA”) [Cal. Lab. Code, ss. 2698, et seq.] in California Superior Court for the County of Los Angeles. In the complaint, captioned Ibarra v. Stadco (LASC Case No. 23STCV26591), a former employee of Stadco, sought to recover alleged damages (including backpay from his date of termination and emotional distress), unpaid underpaid wages, penalties, attorney’s fees and costs of suit on his own behalf based on allegations of age and disability discrimination and wage and hour violations. The former employee’s individual claims would have been subject to private arbitration. In addition, the former employee seeks to recover civil penalties under PAGA on behalf of a group of similarly situated aggrieved employees based upon all paychecks issues since July 21, 2022, together with his attorney’s fees and costs of suit, for certain violations of the California Labor Code. For purposes of this action, “aggrieved employees” means all non-exempt employees of Stadco in California since July 21, 2022. The PAGA claim may not be privately arbitrated, and any settlement must be approved by the court. Stadco has retained outside legal counsel to defend this action. The parties participated in a mediation on June 26, 2024, and were able to reach a resolution within the Company’s expectations. Final settlement payment on the individual claims was due and paid in August 2024.

On October 8, 2024, the Los Angeles County (CA) Superior Court approved the settlement of the Plaintiff’s claim for imposition of civil penalties pursuant to the PAGA. Under the terms of the PAGA Settlement Agreement, the full PAGA settlement amount was paid by Stadco on December 12, 2024.

​

39

Table of Contents

Item 6. Exhibits.

Exhibit Index

Exhibit No. |  | Description |  | Incorporated by Reference Form |  | File No. |  | Date Filed |  | Exhibit No. |  | Filed or Furnished Herewith
3.1 | ​ | Certificate of Incorporation of the Registrant | ​ | SB-2 | ​ | 333-133509 | ​ | August 28, 2006 | ​ | 3.1 | ​ | ​
3.2 | ​ | Amended and Restated By-laws of the Registrant | ​ | 8-K | ​ | 000-51378 | ​ | February 3, 2014 | ​ | 3.1 | ​ | ​
3.3 | ​ | Certificate of Designation for Series A Convertible Preferred Stock of the Registrant | ​ | 8-K | ​ | 000-51378 | ​ | March 3, 2006 | ​ | 3.1 | ​ | ​
3.4 | ​ | Certificate of Amendment to Certificate of Designation for Series A Convertible Preferred Stock of the Registrant | ​ | 10-Q | ​ | 000-51378 | ​ | November 12, 2009 | ​ | 3.5 | ​ | ​
31.1 | ​ | Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | X
31.2 | ​ | Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | X
32.1 | ​ | Certification of Chief Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | X
101.INS | ​ | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | X
101.SCH | ​ | XBRL Taxonomy Extension Schema Document | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | X
101.CAL | ​ | XBRL Taxonomy Extension Calculation Linkbase Document | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | X
101.DEF | ​ | XBRL Taxonomy Extension Definition Linkbase Document | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | X
101.LAB | ​ | XBRL Taxonomy Extension Label Linkbase Document | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | X
101.PRE | ​ | XBRL Taxonomy Extension Presentation Linkbase Document | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | X
104 | ​ | Cover Page Interactive Data File – The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | X

​

​

​

40

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

|  | TechPrecision Corporation
April 8, 2025 | By: | /s/ Barbara M. Lilley
|  | Barbara M. Lilley
​ | ​ | Controller, Ranor, Inc.
|  | (Principal Financial Officer and Principal Accounting Officer)

​

​

41